<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Sports Act. Living</journal-id>
<journal-title>Frontiers in Sports and Active Living</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Sports Act. Living</abbrev-journal-title>
<issn pub-type="epub">2624-9367</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fspor.2025.1662761</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sports and Active Living</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The effect of repeated sprints on immunological modulation and the role of fat-free mass, biological maturation and dietary inflammatory index in male athletes: a quasi-experimental study with insights for training loads control</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>de Almeida-Neto</surname><given-names>Paulo F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2772474/overview" />
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/></contrib>
<contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>E. Alana D.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/></contrib>
<contrib contrib-type="author"><name><surname>de Assis</surname><given-names>Gilmara G.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/401338/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/></contrib>
<contrib contrib-type="author"><name><surname>Suzuki</surname><given-names>Katsuhiko</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/212359/overview" /><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/></contrib>
<contrib contrib-type="author"><name><surname>da Costa</surname><given-names>Roberto F.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1116947/overview" />
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/></contrib>
<contrib contrib-type="author"><name><surname>Atan&#x00E1;sio</surname><given-names>L&#x00ED;via de Melo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/></contrib>
<contrib contrib-type="author"><name><surname>Pinto</surname><given-names>Vanessa Carla Monteiro</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Aidar</surname><given-names>Felipe J.</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/779640/overview" /><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Cabral</surname><given-names>Breno Guilherme de Ara&#x00FA;jo Tin&#x00F4;co</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/776990/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Dantas</surname><given-names>Paulo Moreira Silva</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/709152/overview" /><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Health Sciences Center, Federal University of Rio Grande do Norte. Natal</institution>, <addr-line>Rio Grande do Norte</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Escola Superior Desporto e Lazer, Instituto Polit&#x00E9;cnico de Viana do Castelo, Rua Escola Industrial e Comercial de Nun&#x2019;&#x00C1;lvares</institution>, <addr-line>Viana do Castelo</addr-line>, <country>Portugal</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Sport Physical Activity and Health Research &#x0026; Innovation Center</institution>, <addr-line>Viana do Castelo</addr-line>, <country>Portugal</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>Faculty of Sport Sciences, Waseda University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
<aff id="aff5"><label><sup>5</sup></label><institution>Faculty of Health Sciences, Universidad Aut&#x00F3;noma de Chile</institution>, <addr-line>Providencia</addr-line>, <country>Chile</country></aff>
<aff id="aff6"><label><sup>6</sup></label><institution>Federal University of Sergipe, UFS</institution>, <addr-line>S&#x00E3;o Cristov&#x00E3;o</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/402620/overview">Giuseppe D&#x0027;Antona</ext-link>, University of Pavia, Italy</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/285388/overview">Ana Maria Teixeira</ext-link>, University of Coimbra, Portugal</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/555988/overview">Alexandre Abilio De Souza Teixeira</ext-link>, University of S&#x00E3;o Paulo, Brazil</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Paulo F. de Almeida-Neto <email>paulo.neto.095@ufrn.edu.br</email> Breno Guilherme de Ara&#x00FA;jo Tin&#x00F4;co Cabral <email>brenotcabral@gmail.com</email> Paulo Moreira Silva Dantas <email>pgdantas@icloud.com</email></corresp>
<fn fn-type="other" id="fn001"><label><sup>&#x2020;</sup></label><p>ORCID Paulo F. de Almeida-Neto <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-2860-2260">orcid.org/0000-0002-2860-2260</ext-link> Breno Guilherme de Ara&#x00FA;jo Tin&#x00F4;co Cabral <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-9966-9956">orcid.org/0000-0002-9966-9956</ext-link> Paulo Moreira Silva Dantas <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-9217-7107">orcid.org/0000-0002-9217-7107</ext-link></p></fn>
</author-notes>
<pub-date pub-type="epub"><day>23</day><month>09</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>7</volume><elocation-id>1662761</elocation-id>
<history>
<date date-type="received"><day>09</day><month>07</month><year>2025</year></date>
<date date-type="accepted"><day>03</day><month>09</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 de Almeida-Neto, Fernandes, de Assis, Suzuki, da Costa, Atan&#x00E1;sio, Pinto, Aidar, Cabral and Dantas.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>de Almeida-Neto, Fernandes, de Assis, Suzuki, da Costa, Atan&#x00E1;sio, Pinto, Aidar, Cabral and Dantas</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>Repeated sprint exercise (RSE) induces inflammation, which may be modulated by fat-free mass (FFM), biological maturation (BM), and dietary patterns, assessed by the Dietary Inflammatory Index (DII).</p>
</sec><sec><title>Aim</title>
<p>To examine the influences of FFM, BM, and DII on cytokine responses to RSE in male athletes.</p>
</sec><sec><title>Methods</title>
<p>A study with a quasi-experimental approach and cross-sectional design with a sample of 30 male athletes (20-adolescents, 10-adults). Blood samples were collected pre-, immediately after, 2&#x2005;h and 24&#x2005;h after RSE (3-sets of 6&#x2009;&#x00D7;&#x2009;35-m sprints). IL-1&#x03B2;, IL-6, IL-8, and IL-10 were analyzed via flow cytometry. FFM was assessed by DXA, BM by predictive models, and DII by 24&#x2005;h dietary recalls. Prior exploratory analyses included Spearman&#x0027;s and partial correlations, and Mann&#x2013;Whitney-<italic>U</italic>-tests. Main analyses were conducted using Generalized-Linear-Mixed-Models (GLMM).</p>
</sec><sec><title>Results</title>
<p>The GLMMs confirmed that BM, FFM, and DII significantly influenced cytokine responses (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). FFM emerged as a significant predictor of IL-1&#x03B2; (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.0023). For IL-6, there was a time effect (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) and a Time&#x2009;&#x00D7;&#x2009;BM interaction (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.040), with FFM and DII being significant predictors in both groups. A similar interaction was observed for IL-8 (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.036). For IL-10, there was a Time&#x2009;&#x00D7;&#x2009;BM interaction (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001), where adults showed superiority over adolescents (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). <italic>Post hoc</italic> analyses revealed that adolescents with lower FFM had a more prolonged inflammatory response (increased-IL-6), while adults with higher FFM demonstrated a more effective anti-inflammatory capacity (increased-IL-10).</p>
</sec><sec><title>Conclusion</title>
<p>FFM, BM, and DII play key roles in shaping the inflammatory response to RSE and should be considered when prescribing training loads to optimize recovery and performance.</p>
</sec>
</abstract>
<abstract abstract-type="graphical"><title>Graphical Abstract</title>
<p>
<fig position="anchor">
<graphic xlink:href="fspor-07-1662761-ga001.tif" position="anchor"><alt-text content-type="machine-generated">A quadrant diagram illustrates interactions between Dietary Inflammatory Index (DII) scores and fat-free mass (FFM) in modulating inflammation. The vertical axis represents DII score (low to high) and the horizontal axis represents FFM (low to high), with modulation influenced by biological maturation. Top left quadrant (high DII, low FFM) shows prolonged inflammatory response. Bottom left (low DII, low FFM) shows diet-influenced inflammation. Top right (high DII, high FFM) shows efficient anti-inflammatory modulation. Bottom right (low DII, high FFM) shows FFM-driven anti-inflammatory response. Icons visually represent diet, inflammation, and muscle mass.</alt-text>
</graphic>
</fig></p>
</abstract>
<kwd-group>
<kwd>cytokines</kwd>
<kwd>inflammation</kwd>
<kwd>high-intensity exercise</kwd>
<kwd>sport</kwd>
<kwd>diet
</kwd>
</kwd-group><counts>
<fig-count count="4"/>
<table-count count="3"/><equation-count count="1"/><ref-count count="65"/><page-count count="16"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Exercise Physiology</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1"><title>Highlights</title>
<list list-type="simple">
<list-item><label>&#x2022;</label>
<p>Fat-free mass (FFM) and Dietary Inflammatory Index (DII) are significant predictors of post-exercise cytokine responses. FFM influences both pro-inflammatory (IL-6 &#x0026; IL-8) and anti-inflammatory (IL-10) responses, while DII is associated with a more efficient modulation of the immune response.</p></list-item>
<list-item><label>&#x2022;</label>
<p>Biological maturation is a key determinant of the immune response to exercise. Less mature athletes (adolescents with lower FFM) exhibit a more prolonged inflammatory response, whereas more mature athletes (adults with higher FFM) demonstrate a more effective and acute anti-inflammatory capacity.</p></list-item>
</list>
</sec>
<sec id="s2" sec-type="intro"><title>Introduction</title>
<p>Fat-free mass (FFM), particularly, the skeletal muscle tissue plays an essential role in immunoinflammatory regulation through the expression of myokines. In fact, the muscle is considered an endocrine organ due to an increased release of such myokines as interleukin-6 (IL-6) and interleukin-10 (IL-10) (<xref ref-type="bibr" rid="B1">1</xref>), also known as exerkines, in response to mechanical and metabolic stress induced by high-intensity exercises (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). IL-6 is involved in metabolic adaptations and contribute to inflammatory processes, while IL-10 essentially exerts an anti-inflammatory function that supports muscle recover (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>Athletes involved in intermittent sports, such as soccer, basketball, and handball, are frequently exposed to repeated high-intensity efforts interspersed with brief recovery periods (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). This type of physical demand elicits substantial metabolic and mechanical stress, which in turn activates immune and inflammatory pathways, including the release of myokines (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Previously, it was evidenced that the sport discipline (jiu-jitsu, soccer, and volleyball) did not exert a significant influence on the immune responses derived from repeated sprint exercise (RSE) in adolescent athletes of intermittent sports, suggesting that the physiological demands at the immunological level are similar across different intermittent sports (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>These athletes are particularly susceptible to acute and chronic inflammatory responses due to the cyclical nature of training and competition, which may influence performance, recovery, and injury risk (<xref ref-type="bibr" rid="B9">9</xref>). Understanding the inflammatory milieu in this context is critical, especially because the regulation of pro- and anti-inflammatory cytokines can impact the balance between adaptation and overtraining (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>The RSE is a high intensity short training strategy for athletes engaged in intermittent sports (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). We have previously shown that RSE induces an increase in leukocyte counts and the neutrophil-to-lymphocyte ratio in adolescents for up to two hours after the exercise, suggesting its modulatory effect on inflammatory processes (<xref ref-type="bibr" rid="B10">10</xref>). Also, such effect seems to be even higher in adults (<xref ref-type="bibr" rid="B8">8</xref>). This led to the sense that the biological maturation (BM) might be a modulator of immune responses to RSE (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>). However, inflammatory responses may be influenced by several other factors like dietary patterns (<xref ref-type="bibr" rid="B15">15</xref>). The BM status is determined by various markers associated with physiological mechanisms that promote increases in the total FFM, especially during adolescence (<xref ref-type="bibr" rid="B16">16</xref>), like secondary sexual characteristics (pubertal stages), peak height velocity (PHV), and the degree of epiphyseal ossification (skeletal maturation) (<xref ref-type="bibr" rid="B14">14</xref>). Thus, it is possible that adolescent muscle production of myokines is influenced by BM stages.</p>
<p>However, to investigate how FFM levels can modulate exercise-induced myokine release it is necessary to control both BM and dietary patterns. This can be achieved through subgroup analyses based on the levels of FFM and dietary patterns or through appropriate statistical techniques such as partial Pearson correlation or analysis of covariance (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). FFM is determined using dual-energy x-ray absorptiometry (DXA) (<xref ref-type="bibr" rid="B19">19</xref>), and dietary patterns can be evaluated through a 24-h dietary recalls (24h-R) of the Dietary Inflammatory Index (DII) (<xref ref-type="bibr" rid="B20">20</xref>). It is also possible to verify relationships among these variables in adults and observe the behavior of patterns in adolescents undergoing BM to examine how DII may modulate the effect of FFM on myokine release after RSE in adults.</p>
<p>Although a previous study (<xref ref-type="bibr" rid="B21">21</xref>) by our group investigated the immune response to RSE in athletes of different age groups, it did not address the influence of critical covariates such as FFM and the DII on cytokine modulation. The present study advances the knowledge in the field by uniquely analyzing the role of these variables, particularly DII (<xref ref-type="bibr" rid="B22">22</xref>), an index of easy clinical use for sports nutrition, which can offer valuable insights into the modulation of inflammatory responses in athletes of intermittent sports.</p>
<p>Considering that the inflammatory response to exercise is relevant for adjusting training volume, intensity, and frequency (<xref ref-type="bibr" rid="B14">14</xref>), and that the understanding of factors that modulate mytokine release&#x2014;such as FFM, BM, and DII&#x2014; offers valuable insights for training management in sports; we hypothesized that the relationship between FFM and RSE-induced myokine release is modulated by BM and dietary patterns in adolescents. Therefore, the aim of this study was to analyze the influence of FFM, BM, and DII on myokine release after RSE in male athletes, and to identify inflammatory markers that can guide decision-making in training loads control.</p>
</sec>
<sec id="s3" sec-type="methods"><title>Methods</title>
<p>A study with a quasi-experimental approach and cross-sectional design, was conducted with a sample of 30 male athletes, including 20 adolescents [Age: 12.9&#x2009;&#x00B1;&#x2009;1.1 years; PHV&#x2009;&#x003D;&#x2009;&#x2212;0.7&#x2009;&#x00B1;&#x2009;1.1; Puberty score&#x2009;&#x003D;&#x2009;0.7&#x2009;&#x00B1;&#x2009;1.4; Skeletal maturation&#x2009;&#x003D;&#x2009;0.8&#x2009;&#x00B1;&#x2009;1.2; Total body mass (kg)&#x2009;&#x003D;&#x2009;45.5&#x2009;&#x00B1;&#x2009;16.7; FFM (kg)&#x2009;&#x003D;&#x2009;34.7&#x2009;&#x00B1;&#x2009;10.2] and 10 adults [Age: 23.2&#x2009;&#x00B1;&#x2009;2.1 years; Total body mass (kg)&#x2009;&#x003D;&#x2009;69.9&#x2009;&#x00B1;&#x2009;9.9; FFM (kg)&#x2009;&#x003D;&#x2009;56.1&#x2009;&#x00B1;&#x2009;6.0]. All participants were athletes involved in intermittent sports (soccer, volleyball, basketball, karate, and jiu-jitsu) and regularly participated in regional and national competitions (Tier 3/4) (<xref ref-type="bibr" rid="B23">23</xref>). We emphasize that intermittent sports have similar physiological demands, which is why the sample can be treated as a homogeneous group from this perspective. In addition, all participants reported a weekly training frequency of 4&#x2013;6 days, with daily sessions lasting between 2 and 4&#x2005;h. They were also duly affiliated with the federations of their respective sports and ranked among the top 20 athletes at the regional level in their categories.</p>
<p>The participants were voluntarily recruited from sports clubs in the city of Natal (Northeast Brazil, state of <italic>Rio Grande do Norte</italic>). To be included in the sample, individuals were required to meet the following criteria: (a) engage in at least two training sessions per week, each lasting a minimum of 60&#x2005;min, for at least six months prior to the study; (b) participate in intermittent sports; and (c) have a competition history at the regional, national, or international level for at least one year. Exclusion criteria included: presence of upper respiratory tract infection symptoms, use of supplements with potential effects on the immune system (such as vitamin C, glutamine, among others), diagnosis of clinical diseases, or musculoskeletal injuries within the six months preceding the study.</p>
<p>The study was approved by the Ethics Committee of the Federal University of Rio Grande do Norte (&#x0023;35197020.8.0000.5537) and complies with the Declaration of Helsinki. The study was registered in the Open Science Framework Registries (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17605/OSF.IO/NPZQX">https://doi.org/10.17605/OSF.IO/NPZQX</ext-link>). All participants, and their legal guardians in the case of minors, were informed about the procedures and signed the consent or assent form, as applicable.</p>
<sec id="s3a"><title>Procedures</title>
<p>On the first day of the protocol, participants underwent anthropometric and body composition assessments to estimate BM and quantify FFM levels. At this time, the first 24h-R was also administered to characterize the participants&#x0027; dietary pattern prior to the intervention. After a 24-h interval, resting blood samples were collected. Subsequently, participants were taken to an official athletics track, where they performed a brief five-minute warm-up consisting of jumps and short walks. This was followed by the RSE protocol, which consisted of three sets of six sprints, with 10&#x2005;s of passive rest between sprints and five minutes of passive rest between sets. Additional blood samples were collected immediately after the RSE, as well as 2&#x2005;h and 24&#x2005;h after exercise, to analyze serum cytokine levels at different time points (pre, immediately after, 2&#x2005;h, and 24&#x2005;h after RSE). It is worth noting that, at the 24-h after protocol time point, participants completed the second 24h-R, allowing for the monitoring of dietary intake during the after-intervention period as well (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Procedures. DXA, dual-energy x-ray absorptiometry; 24h-R, 24-h dietary recall; RSE, repeated sprint exercise. This figure was created in <ext-link ext-link-type="uri" xlink:href="https://www.app.napkin.ai">https://www.app.napkin.ai</ext-link> [free version].</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fspor-07-1662761-g001.tif"><alt-text content-type="machine-generated">Diagram illustrating a study timeline related to biological maturation. Panels depict DXA scans, blood sampling before, immediately after, and two hours post-repeated sprint exercise (RSE), and again twenty-four hours after. Icons represent exercise, timing, and dietary recording (24h-R) both before and after the exercise.</alt-text>
</graphic>
</fig>
<p>To ensure blinding regarding the implementation of the RSE protocol, the intervention was conducted by an external collaborator not affiliated with the research team, thereby guaranteeing impartiality at this stage of the study. The 24h-R were administered by a registered dietitian who was also external to the research team. Blood sample collection was carried out by an independent professional, ensuring the neutrality of the procedure. During the laboratory analyses of cytokines, all data were coded to conceal participant identities, preventing evaluators from knowing the origin of each sample. Similarly, during statistical analyses, the data remained masked, making it impossible to identify the groups or individual participants. These measures reinforced the objectivity and integrity of the results obtained.</p>
</sec>
<sec id="s3b"><title>Anthropometry</title>
<p>Body mass was measured using a Filizola&#x00AE; digital scale with a 200&#x2005;kg capacity and 0.10&#x2005;kg precision (S&#x00E3;o Paulo, Brazil). For this assessment, participants were barefoot and wore light clothing. Height was measured using a Sanny&#x00AE; stadiometer with a precision of 0.1&#x2005;mm (S&#x00E3;o Paulo, Brazil). All measurements were taken by a single evaluator following the protocols of the International Society for the Advancement of Kinanthropometry (ISAK) (<xref ref-type="bibr" rid="B24">24</xref>). The intra-observer technical error for anthropometric measurements was &#x2264;1.0&#x0025; (<xref ref-type="bibr" rid="B25">25</xref>). FFM levels were assessed using dual-energy x-ray absorptiometry (DXA) with a LUNAR&#x00AE;/GE PRODIGY - LNR 41.990 device (Washington, DC, USA), employing the enCORE software, GE Healthcare&#x00AE;, version 15.0 (Madison, WI, USA). For adolescent participants, population-specific algorithms were applied (<xref ref-type="bibr" rid="B26">26</xref>). During the assessments, the DXA device operated under the following configuration: whole-body scan; voltage (kV): 76.0; current (mA): 0.150; radiation dose (&#x00B5;G&#x03B3;): 0.4 (very low, with no health risk).</p>
</sec>
<sec id="s3c"><title>Biological maturation profile</title>
<p>The BM profile was assessed through estimates of peak height velocity (PHV), puberty scores, and skeletal maturity. PHV stage was determined using the mathematical model proposed by Moore et al. (<xref ref-type="bibr" rid="B27">27</xref>), for males aged between 8 and 18 years: PHV&#x2009;&#x003D;&#x2009;<italic>&#x2212;8.128741</italic>&#x2009;<italic>&#x002B;</italic>&#x2009;<italic>[0.0070346</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>Age[years]</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>Sitting height(cm)]</italic>, where: (cm)&#x2009;&#x003D;&#x2009;centimeters. Based on the outcome of this model, PHV classification was defined as: Pre PHV (&#x003C;&#x2212;1), Circum PHV (entre &#x2212;1 e 1) e Post PHV (&#x003E;1). The puberty score was calculated using the model proposed by Almeida-Neto et al. (<xref ref-type="bibr" rid="B28">28</xref>), for males aged between 6 and 18 years: <italic>Puberty (score)</italic>&#x2009;<italic>&#x003D;</italic>&#x2009;<italic>&#x2212;17.357</italic>&#x2009;<italic>&#x002B;</italic>&#x2009;<italic>(0.603</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>Age(years)]</italic>&#x2009;<italic>&#x002B;</italic>&#x2009;<italic>[0.127</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>Sitting height(cm)]</italic>. From these scores, Tanner stages were classified as follows: I&#x2009;&#x2264;&#x2009;&#x2212;1.815; II&#x2009;&#x003D;&#x2009;&#x2212;1.816 to &#x2212;0.605; III&#x2009;&#x003D;&#x2009;&#x2212;0.606&#x2013;0.695; IV&#x2009;&#x003D;&#x2009;0.696&#x2013;3.410 &#x0026; V &#x003E;&#x2009;3.410. Stage I corresponds to the prepubertal phase, stages II to IV correspond to the pubertal phase, and stage V represents the postpubertal phase (<xref ref-type="bibr" rid="B28">28</xref>). Skeletal age was determined based on the mathematical model proposed by Cabral et al. (<xref ref-type="bibr" rid="B29">29</xref>): <italic>Skeletal age</italic>&#x2009;<italic>&#x003D;</italic>&#x2009;<italic>&#x2212;11.620</italic> <italic>&#x002B;</italic>&#x2009;<italic>7.004</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>(Height<sub>(m)</sub>)</italic>&#x2009;<italic>&#x002B;</italic>&#x2009;<italic>1.226</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>(Dsex)</italic> <italic>&#x002B;</italic>&#x2009;<italic>0.749</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>(Age<sub>(years)</sub>) - 0.068</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>(Triceps skinfold<sub>(mm)</sub>)</italic>&#x2009;<italic>&#x002B;</italic>&#x2009;<italic>0.214</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>(Corrected arm circumference<sub>(cm)</sub>) - 0.588</italic>&#x2009;<italic>&#x00D7;</italic>&#x2009;<italic>(Humerus diameter<sub>(cm)</sub>)</italic>&#x2009;<italic>&#x002B;</italic>&#x2009;<italic>0.388</italic> <italic>&#x00D7;</italic>&#x2009;<italic>(Femoral diameter<sub>(cm)</sub>)</italic>, where, Dsex: For male sex&#x2009;&#x003D;&#x2009;0; for female sex&#x2009;&#x003D;&#x2009;1. (m): meters. (mm): millimeters. (cm): centimeters. The corrected arm circumference was calculated using the formula: <italic>Corrected Arm Circumference<sub>(cm)</sub></italic>&#x2009;<italic>&#x003D;</italic>&#x2009;<italic>Contracted biceps circumference<sub>(cm)</sub> - (Triceps skinfold<sub>(mm)</sub>/10)</italic>, where, (mm): millimeters. (cm) centimeters. After determining skeletal age, skeletal maturity was classified using the equation proposed by (<xref ref-type="bibr" rid="B30">30</xref>): <italic>Skeletal maturity</italic>&#x2009;<italic>&#x003D;</italic>&#x2009;<italic>Skeletal Age &#x2013; Chronological age</italic>. Based on this difference, skeletal maturation was categorized as follows: Delayed (&#x003C;&#x2212;1.0), Synchronous (between &#x2212;1.0 and 1.0), and Accelerated (&#x003E;1.0).</p>
</sec>
<sec id="s3d"><title>Upper respiratory tract infection symptoms</title>
<p>On the day of the RSE protocol, prior to the first blood collection, upper respiratory tract infection symptoms (URTIS) were assessed using the Wisconsin Upper Respiratory Symptom Survey-21 (WURSS-21) questionnaire (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). Only volunteers who showed no signs of URTIS were retained as participants in the study. It is worth noting that this tool has been previously used in a study involving young athletes and validated for pediatric populations (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). In the present study, none of the participants needed to be excluded due to URTIS symptoms on the day of RSE.</p>
</sec>
<sec id="s3e"><title>Physical activity level</title>
<p>The physical activity level was assessed using the web-based version of the International Physical Activity Questionnaire (IPAQ) (<xref ref-type="bibr" rid="B33">33</xref>), validated for estimating metabolic equivalents (METs) related to energy expenditure from physical activities (<xref ref-type="bibr" rid="B35">35</xref>). The questionnaire covers activities at work, during transportation, household tasks, and leisure/sports. The web-IPAQ automatically calculates METs for habitual energy expenditure, providing scores for each domain and a total score. Based on total METs, the web-IPAQ classifies physical activity level as low, moderate, or high. Participants completed the web-IPAQ in the presence of at least one researcher and, in the case of adolescents, with a guardian to assist with interpreting the questions. All participants in the present study reported a high level of physical activity.</p>
</sec>
<sec id="s3f"><title>Sleep pattern</title>
<p>Sleep patterns were assessed using a sleep diary, in which participants recorded the time they went to bed, perceived time to fall asleep, wake-up time, total time in bed, and whether there were interruptions during the night (<xref ref-type="bibr" rid="B36">36</xref>). Based on these entries, sleep efficiency was calculated (considered good when &#x003E;85&#x0025;) (<xref ref-type="bibr" rid="B36">36</xref>). Records were made on the day of the RSE (referring to the previous night) and on the day following the RSE (referring to the intervention night). All participants in this study presented sleep efficiency between 85&#x0025; and 92&#x0025;.</p>
</sec>
<sec id="s3g"><title>Dietary pattern and dietary inflammatory Index (DII)</title>
<p>The dietary pattern was assessed using two 24h-R, applied on non-consecutive days, including one typical day and one atypical day (<xref ref-type="bibr" rid="B37">37</xref>). To estimate habitual intake, the <italic>Brazilian Food Composition Table</italic> (<xref ref-type="bibr" rid="B38">38</xref>) and the virtualized <italic>Multiple Source Method</italic> (version 1.0.1.87) were used to adjust for intra- and interpersonal variability (<xref ref-type="bibr" rid="B39">39</xref>). The inflammatory potential of the diet was measured using the DII, which quantifies the pro- or anti-inflammatory effect of diet based on scores associated with inflammatory biomarkers and health outcomes (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>The DII calculation was based on the regional dietary pattern of the city of Natal (Northeast Brazil), where the participants of the present study live and train. The specific version used was characterized and validated by the BRAZUCA study (<xref ref-type="bibr" rid="B22">22</xref>), which includes 35 of the 45 items from the original DII model described by Shivappa et al. (<xref ref-type="bibr" rid="B41">41</xref>). It is noteworthy that the 10 additional items from the original model were not assessed in the 24h-R analyses of the participants in this study, aligning with the specific parameters adapted from the BRAZUCA study (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Each parameter was assigned a score of &#x002B;1 (pro-inflammatory), &#x2212;1 (anti-inflammatory), or 0 (neutral). The DII score was calculated based on the Z-score of individual intake, converted to a centered percentile and weighted by the nutrient&#x0027;s inflammatory effect score. The global DII corresponds to the sum of the individual parameter values and is interpreted as follows: anti-inflammatory diet (&#x003C;0) or pro-inflammatory diet (&#x2265;0) (<xref ref-type="bibr" rid="B42">42</xref>). Details of the DII analysis are provided in <xref ref-type="sec" rid="s13">Supplementary Material 1</xref> (Data spreadsheet).</p>
</sec>
<sec id="s3h"><title>Repeated sprint exercise</title>
<p>In the 24&#x2005;h prior to the RSE protocol, participants were instructed to refrain from engaging in high-intensity physical activities. The RSE involved 18 high-intensity sprints performed on an official athletics track, under an average temperature of 26.8&#x2009;&#x00B1;&#x2009;0.8&#x00B0;C. The protocol was divided into three sets, each consisting of six 35-m sprints with 10&#x2005;s of passive rest between repetitions. Between sets, participants were given a 5-min passive rest period, during which they remained seated on chairs with back support and knees flexed at 90&#x00B0;. During the RSE, participants received verbal encouragement, and the rest intervals between each sprint were monitored by two timekeepers. A third timekeeper monitored the rest periods between sets. All timekeepers used digital stopwatches (TecTime&#x00AE;, S&#x00E3;o Paulo, Brazil). Participants were instructed to sprint at maximal effort to ensure the high intensity of the exercise.</p>
<p>The Rating of Perceived Exertion (RPE) scale, proposed by Borg (<xref ref-type="bibr" rid="B43">43</xref>), was used to assess the subjective intensity of the RSE. The scale was applied immediately after the final sprint. This visual, monochromatic scale ranges from 6 to 20, where 6 corresponds to complete rest and 20 to maximal effort. Participants underwent prior familiarization with the RPE scale 72&#x2005;h before the RSE and were re-familiarized on the day of the protocol. All participants reported RPE scores between 17 and 20, indicating a high-intensity effort during RSE.</p>
</sec>
<sec id="s3i"><title>Blood analyses</title>
<p>At each time point in the present study (pre, immediately after, 2&#x2005;h, and 24&#x2005;h after RSE), 10&#x2005;ml of peripheral blood was collected from the antecubital vein using the vacuum method. The blood was stored in dry tubes (BD-Vacutainer, 5.4&#x2005;mg Plus Plastic) and processed for laboratory analysis. We analyzed the serum concentrations of the cytokines [interleukin (IL)] IL-1&#x03B2;, IL-6, IL-8 and IL-10 (<xref ref-type="bibr" rid="B44">44</xref>). For this purpose, peripheral blood samples were assessed by flow cytometry using a BD Biosciences&#x00AE; device (Model: BD FACSCanto&#x2122; II Flow Cytometer, Serial Number: V96100619, New York, USA), with the BD&#x2122; Cytometric Bead Array (CBA) Human Inflammatory Cytokines kit (S&#x00E3;o Paulo, Brazil). All procedures followed the manufacturer&#x0027;s instructions provided in the kit manual (<xref ref-type="bibr" rid="B45">45</xref>). After flow cytometry, the data were processed using BD Biosciences&#x00AE; FCAP Array&#x2122; software (Version 3.0; New York, USA).</p>
</sec>
<sec id="s3j"><title>Statistical analysis</title>
<p>All statistical analyses were performed using the open-source software JAMOVI&#x00AE; (version 2.3, Sidney, Australia), and figures were produced using GraphPad Prism&#x00AE; (version 8.01, California, USA). The significance level was set at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p>
<sec id="s3j1"><title>Preliminary non-parametric analyses</title>
<p>Data distribution was assessed using the Shapiro&#x2013;Wilk test, skewness and kurtosis coefficients (acceptable range: &#x2212;1.96 to &#x002B;1.96), and visual inspection of Q-Q plots. Since assumptions of normality were violated, initial analyses relied on non-parametric tests as an exploratory step.</p>
<p>Associations between FFM and cytokine concentrations were evaluated using Spearman&#x0027;s rank correlation coefficient (<italic>&#x03C1;</italic>). To account for potential confounders, partial correlations were conducted, controlling for BM in adolescents (puberty score, PHV, and skeletal maturity) and for the DII in both adolescents and adults. Ninety-five percent confidence intervals (95&#x0025; CI) for Spearman&#x0027;s coefficients were estimated through bias-corrected bootstrapping with 1,000 resamples (<xref ref-type="bibr" rid="B46">46</xref>). The magnitude of Spearman&#x0027;s <italic>&#x03C1;</italic> was interpreted as (<xref ref-type="bibr" rid="B47">47</xref>): insignificant (&#x003C;0.10), weak (0.10&#x2013;0.39), moderate (0.40&#x2013;0.69), strong (0.70&#x2013;0.89), and very strong (0.90&#x2013;1.00).</p>
<p>For group comparisons, participants were categorized by median split into lower vs. higher subgroups for FFM, DII, and BM stage, separately within adolescents and adults. Percent changes in cytokine concentrations (&#x0394;&#x0025;) across time points were compared using the Mann&#x2013;Whitney <italic>U</italic>-test. Effect sizes were reported as rank-biserial correlation coefficients (<xref ref-type="bibr" rid="B48">48</xref>) and interpreted as (<xref ref-type="bibr" rid="B49">49</xref>): small (&#x2264;0.05), medium (0.06&#x2013;0.25), large (0.26&#x2013;0.50), or very large (&#x003E;0.50).</p>
<p>Samples were categorized based on the median split of the following variables of interest:
<list list-type="simple">
<list-item><label>&#x2022;</label>
<p>FFM (lower vs. higher);</p></list-item>
<list-item><label>&#x2022;</label>
<p>DII (lower vs. higher);</p></list-item>
<list-item><label>&#x2022;</label>
<p>Stage of BM [Pre-PHV (lower mature) vs. Circum/Post-PHV (higher mature)].</p></list-item>
</list>We emphasize that age groups were considered in this process, as described below: (i) adolescents with lower levels vs. adolescents with higher levels; (ii) adults with lower levels vs. adults with higher levels. Thus, comparisons were made within each age group.</p>
<p>Thus, when grouping the subjects for the sub-analyses, the division was balanced: 50&#x0025; for <italic>lower levels</italic> and 50&#x0025; for <italic>higher levels</italic>, as shown below:
<list list-type="simple">
<list-item><label>&#x2022;</label>
<p>Adolescents FFM lower (<italic>n</italic>&#x2009;&#x003D;&#x2009;10) vs. Adolescents FFM higher (<italic>n</italic>&#x2009;&#x003D;&#x2009;10);</p></list-item>
<list-item><label>&#x2022;</label>
<p>Adults FFM lower (<italic>n</italic>&#x2009;&#x003D;&#x2009;05) vs. Adults FFM higher (<italic>n</italic>&#x2009;&#x003D;&#x2009;05);</p></list-item>
<list-item><label>&#x2022;</label>
<p>Adolescents DII lower (<italic>n</italic>&#x2009;&#x003D;&#x2009;10) vs. Adolescents DII higher (<italic>n</italic>&#x2009;&#x003D;&#x2009;10);</p></list-item>
<list-item><label>&#x2022;</label>
<p>Adults DII lower (<italic>n</italic>&#x2009;&#x003D;&#x2009;05) vs. Adults DII higher (<italic>n</italic>&#x2009;&#x003D;&#x2009;05);</p></list-item>
<list-item><label>&#x2022;</label>
<p>Adolescents BM lower (<italic>n</italic>&#x2009;&#x003D;&#x2009;10) vs. Adolescents BM higher (<italic>n</italic>&#x2009;&#x003D;&#x2009;10).</p></list-item>
</list>Subsequently, percent changes in cytokine levels (&#x0394;&#x0025;) between subgroups were compared. &#x0394;&#x0025; was calculated as:<disp-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="UDM1"><mml:mrow><mml:mi mathvariant="normal">&#x0394;</mml:mi><mml:mtext>&#x0025;</mml:mtext></mml:mrow><mml:mspace width="thickmathspace" /><mml:mo>=</mml:mo><mml:mspace width="thickmathspace" /><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">After</mml:mi></mml:mrow><mml:mspace width="thickmathspace" /><mml:mrow><mml:mi mathvariant="normal">RSE</mml:mi></mml:mrow><mml:mspace width="thickmathspace" /><mml:mrow><mml:mi mathvariant="normal">value</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi mathvariant="normal">Pre</mml:mi></mml:mrow><mml:mspace width="thickmathspace" /><mml:mrow><mml:mi mathvariant="normal">RSE</mml:mi></mml:mrow><mml:mspace width="thickmathspace" /><mml:mrow><mml:mi mathvariant="normal">value</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mtext>&#x2013;</mml:mtext><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo>&#x00D7;</mml:mo><mml:mn>100</mml:mn></mml:math></disp-formula></p>
</sec>
<sec id="s3j2"><title><italic>Post hoc</italic> statistical power</title>
<p>Since 16 correlation analyses were performed between FFM and various cytokines across four time points (pre, immediately after, 2&#x2005;h, and 24&#x2005;h after RSE), Bonferroni correction was applied to control for type I error. The adjusted alpha level (adjusted p) was set at <italic>&#x003C;0.003125</italic> for correlations.</p>
<p>Similarly, 12 subgroup comparisons were conducted for &#x0394;&#x0025; values across three after RSE time points (immediately after, 2&#x2005;h, and 24&#x2005;h). For these comparisons, the adjusted <italic>p</italic>-value was defined as <italic>&#x003C;0.0042</italic>.</p>
<p><italic>Post hoc</italic> power analyses were conducted for the main significant findings (based on the adjusted <italic>p</italic>-values), indicating statistical power greater than 0.80 for effects with r&#x2009;&#x2265;&#x2009;0.66. This provides greater confidence in the inferences drawn in these cases. Power analyses were performed using G&#x002A;Power software (version 3.1, D&#x00FC;sseldorf, Germany). Nevertheless, caution is advised when interpreting subgroup results with small samples, such as the adult group, due to lower statistical power.</p>
</sec>
<sec id="s3j3"><title>Main analysis: generalized linear mixed models (GLMM)</title>
<p>Given the longitudinal and repeated-measures nature of the dataset (four time points per participant: pre, immediately after, 2&#x2005;h, and 24&#x2005;h after RSE), the small and unbalanced sample size (20 adolescents, 10 adults), and the need to control for covariates, the primary analyses were performed using Generalized Linear Mixed Models (GLMM). This approach allowed us to: (i) leverage the within-subject design, (ii) adjust for individual differences in FFM and DII, and (iii) provide greater robustness against violations of normality and sample imbalance.</p>
<p>GLMMs were implemented in JAMOVI&#x00AE; using the GAMLj module. For each cytokine (IL-1&#x03B2;, IL-6, IL-8, IL-10), log-transformed concentrations were specified as the dependent variable, assuming a Gamma distribution with log link function due to the skewness of cytokine data. The fixed-effects structure included:
<list list-type="simple">
<list-item><label>&#x2022;</label>
<p>Time (four levels: pre, immediately after, 2&#x2005;h and 24&#x2005;h after RSE),</p></list-item>
<list-item><label>&#x2022;</label>
<p>Age group [BM] (adolescents vs. adults),</p></list-item>
<list-item><label>&#x2022;</label>
<p>FFM (standardized <italic>z</italic>-scores),</p></list-item>
<list-item><label>&#x2022;</label>
<p>DII (standardized <italic>z</italic>-scores),</p></list-item>
<list-item><label>&#x2022;</label>
<p>and the interaction Time&#x2009;&#x00D7;&#x2009;Age group.</p></list-item>
</list></p>
<p>Random effects were modeled at the participant level (ID), with random intercepts and slopes for time (1&#x2009;&#x002B;&#x2009;Time &#x007C; ID), thereby accounting for intra-individual variability. Estimation was based on restricted maximum likelihood (REML), and convergence was checked across multiple optimizers (<italic>bobyqa</italic>, <italic>Nelder-Mead</italic>, <italic>nloptwrap</italic>).</p>
<p>In our study, the repeated-measures design, with data collection at four time points, allowed us to use each athlete as their own control. The analysis using GLMM was specifically adopted to model intra-subject effects over time, mitigating the risks associated with the absence of a control group.</p>
</sec>
<sec id="s3j4"><title>Model outputs and <italic>post hoc</italic> testing</title>
<p>For each model, type III Wald chi-square tests were used to evaluate omnibus fixed effects. Fixed-effect parameter estimates (B), standard errors (SE), <italic>z</italic>-values, <italic>p</italic>-values, and 95&#x0025; confidence intervals were reported. Estimated marginal means (EMMs) were calculated, and pairwise comparisons between time points were adjusted using Bonferroni correction. Interaction effects (Time&#x2009;&#x00D7;&#x2009;Age group) were explored through simple-effects analyses, keeping other covariates constant at their means.</p>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="results"><title>Results</title>
<p>In the total sample analysis, a positive correlation was identified between FFM and IL-6 levels both pre and immediately after RSE, as well as a negative correlation with IL-10 at 24&#x2005;h after RSE (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). Among adolescents, a positive association was found between FFM and IL-6 at 2&#x2005;h after RSE, while negative correlations were observed with IL-6 and IL-8 at 24&#x2005;h after RSE.</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Correlation analysis of FFM levels with cytokine levels considering the interference of BM in adolescent athletes.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="5">Cytokine</th>
<th valign="top" align="center" rowspan="2" colspan="4">Total sample (<italic>n</italic>&#x2009;&#x003D;&#x2009;30)</th>
<th valign="top" align="center" colspan="8">Adolescent (<italic>n</italic>&#x2009;&#x003D;&#x2009;20)</th>
<th valign="top" align="center" rowspan="2" colspan="4">Adult (<italic>n</italic>&#x2009;&#x003D;&#x2009;10)</th>
</tr>
<tr>
<th valign="top" align="center" colspan="4"/>
<th valign="top" align="center" colspan="4">Controlling BM markers (partial correlation)</th>
</tr>
<tr>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
</tr>
<tr>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
</tr>
<tr>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">0.148</td>
<td valign="top" align="center">0.444</td>
<td valign="top" align="center">&#x2212;0.232</td>
<td valign="top" align="center">0.493</td>
<td valign="top" align="center">0.118</td>
<td valign="top" align="center">0.619</td>
<td valign="top" align="center">&#x2212;0.365</td>
<td valign="top" align="center">0.547</td>
<td valign="top" align="center">&#x2212;0.184</td>
<td valign="top" align="center">0.480</td>
<td valign="top" align="center">&#x2212;0.735</td>
<td valign="top" align="center">0.473</td>
<td valign="top" align="center">0.209</td>
<td valign="top" align="center">0.562</td>
<td valign="top" align="center">&#x2212;0.691</td>
<td valign="top" align="center">0.858</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">0.423<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0022</td>
<td valign="top" align="center">0.059</td>
<td valign="top" align="center">0.699</td>
<td valign="top" align="center">0.143</td>
<td valign="top" align="center">0.548</td>
<td valign="top" align="center">&#x2212;0.301</td>
<td valign="top" align="center">0.583</td>
<td valign="top" align="center">0.200</td>
<td valign="top" align="center">0.441</td>
<td valign="top" align="center">&#x2212;0.593</td>
<td valign="top" align="center">0.806</td>
<td valign="top" align="center">0.042</td>
<td valign="top" align="center">0.919</td>
<td valign="top" align="center">&#x2212;0.774</td>
<td valign="top" align="center">0.805</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">0.358</td>
<td valign="top" align="center">0.057</td>
<td valign="top" align="center">&#x2212;0.024</td>
<td valign="top" align="center">0.629</td>
<td valign="top" align="center">&#x2212;0.301</td>
<td valign="top" align="center">0.197</td>
<td valign="top" align="center">&#x2212;0.665</td>
<td valign="top" align="center">0.150</td>
<td valign="top" align="center">&#x2212;0.116</td>
<td valign="top" align="center">0.657</td>
<td valign="top" align="center">&#x2212;0.569</td>
<td valign="top" align="center">0.603</td>
<td valign="top" align="center">&#x2212;0.164</td>
<td valign="top" align="center">0.657</td>
<td valign="top" align="center">&#x2212;0.789</td>
<td valign="top" align="center">0.585</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.034</td>
<td valign="top" align="center">0.862</td>
<td valign="top" align="center">&#x2212;0.401</td>
<td valign="top" align="center">0.298</td>
<td valign="top" align="center">0.292</td>
<td valign="top" align="center">0.212</td>
<td valign="top" align="center">&#x2212;0.159</td>
<td valign="top" align="center">0.674</td>
<td valign="top" align="center">0.508<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">&#x2212;0.138</td>
<td valign="top" align="center">0.844</td>
<td valign="top" align="center">&#x2212;0.752<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0012</td>
<td valign="top" align="center">&#x2212;0.988</td>
<td valign="top" align="center">&#x2212;0.229</td>
</tr>
<tr>
<td valign="top" align="left" colspan="1"/>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
</tr>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">0.203</td>
<td valign="top" align="center">0.290</td>
<td valign="top" align="center">&#x2212;0.153</td>
<td valign="top" align="center">0.534</td>
<td valign="top" align="center">0.199</td>
<td valign="top" align="center">0.400</td>
<td valign="top" align="center">&#x2212;0.284</td>
<td valign="top" align="center">0.628</td>
<td valign="top" align="center">&#x2212;0.254</td>
<td valign="top" align="center">0.325</td>
<td valign="top" align="center">&#x2212;0.690</td>
<td valign="top" align="center">0.572</td>
<td valign="top" align="center">0.486</td>
<td valign="top" align="center">0.154</td>
<td valign="top" align="center">&#x2212;0.261</td>
<td valign="top" align="center">0.946</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">0.377<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">0.039</td>
<td valign="top" align="center">0.639</td>
<td valign="top" align="center">0.132</td>
<td valign="top" align="center">0.580</td>
<td valign="top" align="center">&#x2212;0.287</td>
<td valign="top" align="center">0.584</td>
<td valign="top" align="center">0.233</td>
<td valign="top" align="center">0.368</td>
<td valign="top" align="center">&#x2212;0.606</td>
<td valign="top" align="center">0.798</td>
<td valign="top" align="center">&#x2212;0.006</td>
<td valign="top" align="center">1.000</td>
<td valign="top" align="center">&#x2212;0.689</td>
<td valign="top" align="center">0.699</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">0.328</td>
<td valign="top" align="center">0.083</td>
<td valign="top" align="center">&#x2212;0.037</td>
<td valign="top" align="center">0.615</td>
<td valign="top" align="center">&#x2212;0.003</td>
<td valign="top" align="center">0.992</td>
<td valign="top" align="center">&#x2212;0.479</td>
<td valign="top" align="center">0.522</td>
<td valign="top" align="center">0.142</td>
<td valign="top" align="center">0.587</td>
<td valign="top" align="center">&#x2212;0.386</td>
<td valign="top" align="center">0.660</td>
<td valign="top" align="center">&#x2212;0.079</td>
<td valign="top" align="center">0.838</td>
<td valign="top" align="center">&#x2212;0.673</td>
<td valign="top" align="center">0.801</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">0.209</td>
<td valign="top" align="center">0.276</td>
<td valign="top" align="center">&#x2212;0.146</td>
<td valign="top" align="center">0.556</td>
<td valign="top" align="center">0.331</td>
<td valign="top" align="center">0.154</td>
<td valign="top" align="center">&#x2212;0.047</td>
<td valign="top" align="center">0.628</td>
<td valign="top" align="center">0.196</td>
<td valign="top" align="center">0.450</td>
<td valign="top" align="center">&#x2212;0.520</td>
<td valign="top" align="center">0.666</td>
<td valign="top" align="center">&#x2212;0.673<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">&#x2212;0.925</td>
<td valign="top" align="center">&#x2212;0.118</td>
</tr>
<tr>
<td valign="top" align="left" colspan="1"/>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
</tr>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">0.065</td>
<td valign="top" align="center">0.738</td>
<td valign="top" align="center">&#x2212;0.392</td>
<td valign="top" align="center">0.450</td>
<td valign="top" align="center">0.321</td>
<td valign="top" align="center">0.168</td>
<td valign="top" align="center">&#x2212;0.192</td>
<td valign="top" align="center">0.777</td>
<td valign="top" align="center">&#x2212;0.246</td>
<td valign="top" align="center">0.342</td>
<td valign="top" align="center">&#x2212;0.661</td>
<td valign="top" align="center">0.462</td>
<td valign="top" align="center">0.328</td>
<td valign="top" align="center">0.354</td>
<td valign="top" align="center">&#x2212;0.401</td>
<td valign="top" align="center">0.852</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">0.356</td>
<td valign="top" align="center">0.058</td>
<td valign="top" align="center">&#x2212;0.050</td>
<td valign="top" align="center">0.693</td>
<td valign="top" align="center">0.619<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">0.202</td>
<td valign="top" align="center">0.920</td>
<td valign="top" align="center">0.710<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.001</td>
<td valign="top" align="center">&#x2212;0.014</td>
<td valign="top" align="center">0.922</td>
<td valign="top" align="center">0.745<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0018</td>
<td valign="top" align="center">0.150</td>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">0.333</td>
<td valign="top" align="center">0.078</td>
<td valign="top" align="center">&#x2212;0.068</td>
<td valign="top" align="center">0.668</td>
<td valign="top" align="center">0.014</td>
<td valign="top" align="center">0.955</td>
<td valign="top" align="center">&#x2212;0.508</td>
<td valign="top" align="center">0.552</td>
<td valign="top" align="center">0.261</td>
<td valign="top" align="center">0.312</td>
<td valign="top" align="center">&#x2212;0.367</td>
<td valign="top" align="center">0.730</td>
<td valign="top" align="center">0.333</td>
<td valign="top" align="center">0.349</td>
<td valign="top" align="center">&#x2212;0.400</td>
<td valign="top" align="center">0.889</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">0.009</td>
<td valign="top" align="center">0.964</td>
<td valign="top" align="center">&#x2212;0.306</td>
<td valign="top" align="center">0.353</td>
<td valign="top" align="center">0.239</td>
<td valign="top" align="center">0.310</td>
<td valign="top" align="center">&#x2212;0.255</td>
<td valign="top" align="center">0.702</td>
<td valign="top" align="center">0.371</td>
<td valign="top" align="center">0.143</td>
<td valign="top" align="center">&#x2212;0.307</td>
<td valign="top" align="center">0.794</td>
<td valign="top" align="center">0.143</td>
<td valign="top" align="center">0.694</td>
<td valign="top" align="center">&#x2212;0.754</td>
<td valign="top" align="center">0.800</td>
</tr>
<tr>
<td valign="top" align="left" colspan="1"/>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
</tr>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.091</td>
<td valign="top" align="center">0.639</td>
<td valign="top" align="center">&#x2212;0.510</td>
<td valign="top" align="center">0.364</td>
<td valign="top" align="center">0.012</td>
<td valign="top" align="center">0.960</td>
<td valign="top" align="center">&#x2212;0.459</td>
<td valign="top" align="center">0.514</td>
<td valign="top" align="center">&#x2212;0.552<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0022</td>
<td valign="top" align="center">&#x2212;0.843</td>
<td valign="top" align="center">0.216</td>
<td valign="top" align="center">0.334</td>
<td valign="top" align="center">0.345</td>
<td valign="top" align="center">&#x2212;0.368</td>
<td valign="top" align="center">0.805</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.105</td>
<td valign="top" align="center">0.588</td>
<td valign="top" align="center">&#x2212;0.486</td>
<td valign="top" align="center">0.267</td>
<td valign="top" align="center">&#x2212;0.495<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0026</td>
<td valign="top" align="center">&#x2212;0.803</td>
<td valign="top" align="center">&#x2212;0.092</td>
<td valign="top" align="center">&#x2212;0.160</td>
<td valign="top" align="center">0.540</td>
<td valign="top" align="center">&#x2212;0.609</td>
<td valign="top" align="center">0.480</td>
<td valign="top" align="center">&#x2212;0.061</td>
<td valign="top" align="center">0.868</td>
<td valign="top" align="center">&#x2212;0.700</td>
<td valign="top" align="center">0.676</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.142</td>
<td valign="top" align="center">0.462</td>
<td valign="top" align="center">&#x2212;0.521</td>
<td valign="top" align="center">0.198</td>
<td valign="top" align="center">&#x2212;0.534<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0015</td>
<td valign="top" align="center">&#x2212;0.845</td>
<td valign="top" align="center">&#x2212;0.079</td>
<td valign="top" align="center">&#x2212;0.214</td>
<td valign="top" align="center">0.409</td>
<td valign="top" align="center">&#x2212;0.645</td>
<td valign="top" align="center">0.578</td>
<td valign="top" align="center">&#x2212;0.333</td>
<td valign="top" align="center">0.349</td>
<td valign="top" align="center">&#x2212;0.837</td>
<td valign="top" align="center">0.358</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.440<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0017</td>
<td valign="top" align="center">&#x2212;0.739</td>
<td valign="top" align="center">&#x2212;0.003</td>
<td valign="top" align="center">&#x2212;0.136</td>
<td valign="top" align="center">0.568</td>
<td valign="top" align="center">&#x2212;0.573</td>
<td valign="top" align="center">0.308</td>
<td valign="top" align="center">&#x2212;0.135</td>
<td valign="top" align="center">0.607</td>
<td valign="top" align="center">&#x2212;0.664</td>
<td valign="top" align="center">0.491</td>
<td valign="top" align="center">&#x2212;0.681<xref ref-type="table-fn" rid="table-fn2">&#x002A;</xref></td>
<td valign="top" align="center">0.0030</td>
<td valign="top" align="center">&#x2212;0.962</td>
<td valign="top" align="center">&#x2212;0.038</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>&#x03C1;, Spearman Rho coeficient; FFM, fat-free mass; IL, interleukin; &#x03B2;, Beta; Rho, Spearman&#x0027;s correlation coefficient; CI, confidence interval; BM, biological maturation.</p></fn>
<fn id="table-fn2"><label>&#x002A;</label>
<p>Statistically significant (Bonferroni correction <italic>p</italic>-adjusted <italic>&#x003C;0.003125</italic>).</p></fn>
</table-wrap-foot>
</table-wrap>
<p>When adjusting for BM profile markers (puberty score, PHV, and skeletal maturity) within the adolescent group, the following were observed: a positive correlation between FFM and IL-10 pre RSE; a positive correlation with IL-6 at 2&#x2005;h after RSE; and a negative correlation with IL-1&#x03B2; at 24&#x2005;h after RSE (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<p>Among adults, FFM showed a negative correlation with IL-10 at three time points (pre, 2&#x2005;h, and 24&#x2005;h after RSE), and a positive correlation with IL-6 at 2&#x2005;h after the protocol (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<p>After controlling for the effect of the DII in the correlation analyses between FFM and cytokine levels in the total sample, significant correlations were observed between FFM and IL-6 at the pre RSE time point, and between FFM and IL-10 at 24&#x2005;h after RSE.</p>
<p>In the adult group, significant correlations were identified between FFM and IL-10 both immediately and 24&#x2005;h after RSE. Additionally, after controlling for DII, no significant correlations were found between FFM and cytokine levels in the adolescent group (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Correlation analysis of FFM levels with cytokine levels considering the interference of the inflammatory index of the diet.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="5">Cytokine</th>
<th valign="top" align="center" colspan="4">Total Sample (<italic>n</italic>&#x2009;&#x003D;&#x2009;30)</th>
<th valign="top" align="center" colspan="4">Adolescent (<italic>n</italic>&#x2009;&#x003D;&#x2009;20)</th>
<th valign="top" align="center" colspan="4">Adult (<italic>n</italic>&#x2009;&#x003D;&#x2009;10)</th>
</tr>
<tr>
<th valign="top" align="center" colspan="4">Controlling DII (Partial Correlation)</th>
<th valign="top" align="center" colspan="4">Controlling DII (Partial Correlation)</th>
<th valign="top" align="center" colspan="4">Controlling DII (Partial Correlation)</th>
</tr>
<tr>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
<th valign="top" align="center"><italic>&#x03C1;</italic></th>
<th valign="top" align="center"><italic>p</italic></th>
<th valign="top" align="center" colspan="2">CI 95&#x0025;</th>
</tr>
<tr>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
<th valign="top" align="center" colspan="2">FFM Kg</th>
<th valign="top" align="center" colspan="2">Bootstraps (1.000)</th>
</tr>
<tr>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
<th valign="top" align="center" colspan="4">Pre Repeated Sprints Exercise</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">0.155</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">&#x2212;0.241</td>
<td valign="top" align="center">0.496</td>
<td valign="top" align="center">0.186</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">&#x2212;0.218</td>
<td valign="top" align="center">0.520</td>
<td valign="top" align="center">0.522</td>
<td valign="top" align="center">0.1</td>
<td valign="top" align="center">&#x2212;0.737</td>
<td valign="top" align="center">0.931</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">0.441<xref ref-type="table-fn" rid="table-fn4">&#x002A;</xref></td>
<td valign="top" align="center">0.001</td>
<td valign="top" align="center">0.077</td>
<td valign="top" align="center">0.680</td>
<td valign="top" align="center">0.033</td>
<td valign="top" align="center">0.8</td>
<td valign="top" align="center">&#x2212;0.258</td>
<td valign="top" align="center">0.418</td>
<td valign="top" align="center">&#x2212;0.399</td>
<td valign="top" align="center">0.2</td>
<td valign="top" align="center">&#x2212;0.851</td>
<td valign="top" align="center">0.776</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">0.343</td>
<td valign="top" align="center">0.07</td>
<td valign="top" align="center">&#x2212;0.091</td>
<td valign="top" align="center">0.608</td>
<td valign="top" align="center">&#x2212;0.265</td>
<td valign="top" align="center">0.2</td>
<td valign="top" align="center">&#x2212;0.666</td>
<td valign="top" align="center">0.045</td>
<td valign="top" align="center">&#x2212;0.397</td>
<td valign="top" align="center">0.2</td>
<td valign="top" align="center">&#x2212;0.895</td>
<td valign="top" align="center">0.804</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.015</td>
<td valign="top" align="center">0.9</td>
<td valign="top" align="center">&#x2212;0.364</td>
<td valign="top" align="center">0.320</td>
<td valign="top" align="center">0.228</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x2212;0.148</td>
<td valign="top" align="center">0.574</td>
<td valign="top" align="center">&#x2212;0.661</td>
<td valign="top" align="center">0.053</td>
<td valign="top" align="center">&#x2212;0.981</td>
<td valign="top" align="center">&#x2212;0.171</td>
</tr>
<tr>
<td valign="top" align="left" colspan="1"/>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">Immediately after Repeated Sprints Exercise</td>
</tr>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">0.178</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x2212;0.193</td>
<td valign="top" align="center">0.491</td>
<td valign="top" align="center">0.192</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">&#x2212;0.123</td>
<td valign="top" align="center">0.524</td>
<td valign="top" align="center">0.588</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">&#x2212;0.380</td>
<td valign="top" align="center">0.935</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">0.361</td>
<td valign="top" align="center">0.054</td>
<td valign="top" align="center">0.045</td>
<td valign="top" align="center">0.630</td>
<td valign="top" align="center">0.109</td>
<td valign="top" align="center">0.6</td>
<td valign="top" align="center">&#x2212;0.205</td>
<td valign="top" align="center">0.486</td>
<td valign="top" align="center">&#x2212;0.321</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">&#x2212;0.805</td>
<td valign="top" align="center">0.669</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">0.327</td>
<td valign="top" align="center">0.08</td>
<td valign="top" align="center">&#x2212;0.083</td>
<td valign="top" align="center">0.628</td>
<td valign="top" align="center">0.223</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x2212;0.387</td>
<td valign="top" align="center">0.651</td>
<td valign="top" align="center">&#x2212;0.329</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x2212;0.805</td>
<td valign="top" align="center">0.932</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">0.183</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x2212;0.245</td>
<td valign="top" align="center">0.582</td>
<td valign="top" align="center">0.295</td>
<td valign="top" align="center">0.2</td>
<td valign="top" align="center">&#x2212;0.045</td>
<td valign="top" align="center">0.606</td>
<td valign="top" align="center">&#x2212;0.677<xref ref-type="table-fn" rid="table-fn4">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">&#x2212;0.919</td>
<td valign="top" align="center">&#x2212;0.403</td>
</tr>
<tr>
<td valign="top" align="left" colspan="1"/>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">2&#x2005;h after Repeated Sprints Exercise</td>
</tr>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">0.048</td>
<td valign="top" align="center">0.8</td>
<td valign="top" align="center">&#x2212;0.319</td>
<td valign="top" align="center">0.430</td>
<td valign="top" align="center">&#x2212;0.139</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">&#x2212;0.403</td>
<td valign="top" align="center">0.330</td>
<td valign="top" align="center">0.623</td>
<td valign="top" align="center">0.07</td>
<td valign="top" align="center">&#x2212;0.419</td>
<td valign="top" align="center">0.945</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">0.347</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">&#x2212;0.051</td>
<td valign="top" align="center">0.700</td>
<td valign="top" align="center">0.426</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">0.182</td>
<td valign="top" align="center">0.824</td>
<td valign="top" align="center">0.663</td>
<td valign="top" align="center">0.052</td>
<td valign="top" align="center">0.442</td>
<td valign="top" align="center">0.973</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">0.338</td>
<td valign="top" align="center">0.07</td>
<td valign="top" align="center">&#x2212;0.073</td>
<td valign="top" align="center">0.650</td>
<td valign="top" align="center">0.394</td>
<td valign="top" align="center">0.09</td>
<td valign="top" align="center">&#x2212;0.307</td>
<td valign="top" align="center">0.910</td>
<td valign="top" align="center">0.324</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">&#x2212;0.540</td>
<td valign="top" align="center">0.935</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="center">0.9</td>
<td valign="top" align="center">&#x2212;0.334</td>
<td valign="top" align="center">0.486</td>
<td valign="top" align="center">0.186</td>
<td valign="top" align="center">0.447</td>
<td valign="top" align="center">&#x2212;0.268</td>
<td valign="top" align="center">0.604</td>
<td valign="top" align="center">0.274</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">&#x2212;0.722</td>
<td valign="top" align="center">0.922</td>
</tr>
<tr>
<td valign="top" align="left" colspan="1"/>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
<td valign="top" align="center" colspan="4">24&#x2005;h after Repeated Sprints Exercise</td>
</tr>
<tr>
<td valign="top" align="left">IL-1&#x03B2; (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.087</td>
<td valign="top" align="center">0.6</td>
<td valign="top" align="center">&#x2212;0.533</td>
<td valign="top" align="center">0.327</td>
<td valign="top" align="center">&#x2212;0.342</td>
<td valign="top" align="center">0.1</td>
<td valign="top" align="center">&#x2212;0.622</td>
<td valign="top" align="center">&#x2212;0.126</td>
<td valign="top" align="center">0.660</td>
<td valign="top" align="center">0.051</td>
<td valign="top" align="center">&#x2212;0.478</td>
<td valign="top" align="center">0.943</td>
</tr>
<tr>
<td valign="top" align="left">IL-6 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.124</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">&#x2212;0.472</td>
<td valign="top" align="center">0.256</td>
<td valign="top" align="center">&#x2212;0.351</td>
<td valign="top" align="center">0.1</td>
<td valign="top" align="center">&#x2212;0.627</td>
<td valign="top" align="center">0.013</td>
<td valign="top" align="center">&#x2212;0.365</td>
<td valign="top" align="center">0.3</td>
<td valign="top" align="center">&#x2212;0.877</td>
<td valign="top" align="center">0.640</td>
</tr>
<tr>
<td valign="top" align="left">IL-8 (pg/ml)</td>
<td valign="top" align="center">&#x2212;0.136</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">&#x2212;0.525</td>
<td valign="top" align="center">0.240</td>
<td valign="top" align="center">&#x2212;0.435</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">&#x2212;0.667</td>
<td valign="top" align="center">&#x2212;0.195</td>
<td valign="top" align="center">&#x2212;0.456</td>
<td valign="top" align="center">0.2</td>
<td valign="top" align="center">&#x2212;0.888</td>
<td valign="top" align="center">0.475</td>
</tr>
<tr>
<td valign="top" align="left">IL-10 (pg/ml)</td>
<td valign="top" align="center">0.416<xref ref-type="table-fn" rid="table-fn4">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">&#x2212;0.719</td>
<td valign="top" align="center">0.555</td>
<td valign="top" align="center">&#x2212;0.119</td>
<td valign="top" align="center">0.6</td>
<td valign="top" align="center">&#x2212;0.457</td>
<td valign="top" align="center">0.177</td>
<td valign="top" align="center">&#x2212;0.700<xref ref-type="table-fn" rid="table-fn4">&#x002A;</xref></td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">&#x2212;0.951</td>
<td valign="top" align="center">&#x2212;0.241</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3"><p>&#x03C1;, Spearman rho coeficient; DII, dietary inflammatory index; FFM, fat-free mass; IL, interleukin; &#x03B2;, beta; Rho, Spearman&#x0027;s correlation coefficient; CI, confidence interval; BM, biological maturation.</p></fn>
<fn id="table-fn4"><label>&#x002A;</label>
<p>Statistically significant (Bonferroni correction <italic>p</italic>-adjusted &#x003C;0.003125).</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Adolescents with lower levels of FFM exhibited greater percent variation (&#x0394;&#x0025;) in IL-6 levels at 24&#x2005;h after RSE [r&#x2009;&#x003D;&#x2009;0.66; Power&#x2009;&#x003D;&#x2009;0.81 (<xref ref-type="fig" rid="F2">Figure&#x00A0;2B</xref>)], compared to their peers with higher FFM levels. No significant differences were observed between groups for the other cytokines (<italic>p</italic>&#x2009;&#x003E;&#x2009;0.05) (IL-1&#x03B2;, IL-8 &#x0026; IL-10).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Comparisons of cytokine levels considering the division of groups based on FFM levels (lower vs. higher levels). FFM: Fat-free mass. IL: Interleukin. &#x0394;: Delta Coefficient. &#x002A;Statistically significant (Bonferroni correction <italic>p</italic>-adjusted &#x003C;0.00417).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fspor-07-1662761-g002.tif"><alt-text content-type="machine-generated">A set of eight bar graphs compares cytokine responses (IL-1&#x03B2;, IL-6, IL-8, IL-10) in adolescents (panels A&#x2013;D) and adults (panels E&#x2013;H) with lower versus higher levels of fat-free mass (FFM). Each graph shows percentage change (&#x0394;%) measured immediately after, 2 hours after, and 24 hours after exercise. Results indicate variability by FFM and age group. Significant differences are marked in panel B (IL-6 in adolescents at 24 hours, p=0.001) and panel H (IL-10 in adults at 24 hours, p=0.003). Error bars represent variability across groups.</alt-text>
</graphic>
</fig>
<p>Among adults, individuals with higher FFM levels showed greater percent variation (&#x0394;&#x0025;) in IL-10 levels at 2&#x2005;h after RSE [<italic>r</italic>&#x2009;&#x003D;&#x2009;0.84; Power&#x2009;&#x003D;&#x2009;0.88 (<xref ref-type="fig" rid="F2">Figure&#x00A0;2H</xref>)] compared to those with lower FFM levels. As observed in the adolescent group, no significant differences were found between groups for the remaining cytokines analyzed (<italic>p</italic>&#x2009;&#x003E;&#x2009;0.05) (IL-1&#x03B2;, IL-6 &#x0026; IL-8).</p>
<p>Lower biologically mature adolescents exhibited greater percent variation (&#x0394;&#x0025;) in IL-6 levels at 24&#x2005;h after RSE [<italic>r</italic>&#x2009;&#x003D;&#x2009;0.66; Power&#x2009;&#x003D;&#x2009;0.81 (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>)] compared to their more mature peers. No significant differences between groups were observed for the other cytokines (IL-1&#x03B2;, IL-8 &#x0026; IL-10).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Comparisons of cytokine levels considering the division of the adolescent group based on BM levels (lower vs. higher levels). IL, interleukin; BM, biological maturation; &#x0394;, delta coefficient. &#x002A;Statistically significant (Bonferroni correction <italic>p</italic>-adjusted &#x003C;0.00417).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fspor-07-1662761-g003.tif"><alt-text content-type="machine-generated">Bar charts show the percentage changes in cytokines for adolescents with different BM levels. Chart A: IL-1&#x03B2;, Chart B: IL-6, Chart C: IL-8, Chart D: IL-10. Measurements are taken immediately after, two hours after, and twenty-four hours after exercise. Black bars represent higher BM levels and white bars represent lower BM levels. Chart B shows a significant difference in IL-6 levels after twenty-four hours with p = 0.001. Error bars indicate variability.</alt-text>
</graphic>
</fig>
<p>When adolescents and adults were grouped according to DII levels, differences were observed only among adolescents at 2&#x2005;h after RSE. At this time point, individuals with higher DII levels presented higher IL-6 concentrations compared to those with lower DII levels [<italic>r</italic>&#x2009;&#x003D;&#x2009;0.540; Power&#x2009;&#x003D;&#x2009;0.80 (<xref ref-type="fig" rid="F4">Figure&#x00A0;4C</xref>)]. Additionally, in the adult group, individuals with lower DII levels exhibited higher IL-10 concentrations than their counterparts with higher DII levels immediately after RSE [<italic>r</italic>&#x2009;&#x003D;&#x2009;0.840; Power&#x2009;&#x003D;&#x2009;0.99 (<xref ref-type="fig" rid="F4">Figure&#x00A0;4H</xref>)].</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Comparisons of cytokine levels considering the division of groups based on dietary inflammatory index [DII] levels (lower vs. higher levels). IL, interleukin; &#x0394;, delta coefficient. &#x002A;Statistically significant (Bonferroni correction <italic>p</italic>-adjusted &#x003C;0.00417).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fspor-07-1662761-g004.tif"><alt-text content-type="machine-generated">A set of eight bar graphs illustrates cytokine responses (IL-1&#x03B2;, IL-6, IL-8, IL-10) in adolescents (panels A&#x2013;D) and adults (panels E&#x2013;H) grouped by lower versus higher levels of dietary inflammatory index (DII). Percentage change (&#x0394;%) is shown at three timepoints: immediately after, 2 hours after, and 24 hours after exercise. Panel C shows a significant difference in IL-8 among adolescents at 2 hours (p=0.0039), while panel H shows a significant difference in IL-10 among adults immediately after exercise (p=0.0032). Error bars reflect variability across groups.</alt-text>
</graphic>
</fig>
<p>The GLMM analyses revealed distinct effects of time, age, and covariates (FFM and DII) on cytokine levels. IL-1&#x03B2; showed no significant changes over time or due to the Time&#x2009;&#x00D7;&#x2009;Age group (Adolescent vs. Adult) interaction (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>). However, FFM emerged as a significant predictor, indicating that in both adolescents and adults, individuals with higher FFM presented with elevated levels of IL-1&#x03B2;.</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Generalized linear mixed models (GLMM) results for cytokine responses to repeated sprint exercise (RSE).</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Cytokine</th>
<th valign="top" align="left">Omnibus fixed effects (<italic>&#x03C7;</italic><sup>2</sup>, df, p)</th>
<th valign="top" align="left">Fixed effect estimates [&#x03B2; (95&#x0025; CI), SE, z, p]</th>
<th valign="top" align="left">Significant pairwise comparisons (Bonferroni-adjusted)</th>
<th valign="top" align="left">Simple effects (Time&#x2009;&#x00D7;&#x2009;Age group)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">IL1&#x03B2;</td>
<td valign="top" align="left">- FFM (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;5.19, df&#x2009;&#x003D;&#x2009;1, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.0023&#x002A;);<break/>- Time (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;4.56, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.207);<break/>- Age group trend (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;3.25, df&#x2009;&#x003D;&#x2009;1, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.072);<break/>- Time&#x2009;&#x00D7;&#x2009;Age group (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;3.43, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.330).</td>
<td valign="top" align="left">FFM: &#x03B2;&#x003D;0.078 [0.011&#x2013;0.145], SE&#x2009;&#x003D;&#x2009;0.034, <italic>z</italic>&#x2009;&#x003D;&#x2009;2.28, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.023&#x002A;.</td>
<td valign="top" align="left">There were no significant time contrasts.</td>
<td valign="top" align="left">There were no significant Time&#x2009;&#x00D7;&#x2009;Age group effects.</td>
</tr>
<tr>
<td valign="top" align="left">IL6</td>
<td valign="top" align="left">- Time (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;17.2, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;);<break/>- Time&#x2009;&#x00D7;&#x2009;Age group (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;8.3, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.040&#x002A;);<break/>- FFM (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.007&#x002A;);<break/>- DII (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.005&#x002A;).</td>
<td valign="top" align="left">- Immediately after vs. 24h: <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.245 [0.087&#x2013;0.403], SE&#x2009;&#x003D;&#x2009;0.081, <italic>z</italic>&#x2009;&#x003D;&#x2009;3.04, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.002&#x002A;;<break/>- Pre vs. 24h: <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.159 [0.033&#x2013;0.285], SE&#x2009;&#x003D;&#x2009;0.064, <italic>z</italic>&#x2009;&#x003D;&#x2009;2.47, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.014&#x002A;.</td>
<td valign="top" align="left">- &#x2191; IL-6 immediately after and 2&#x2005;h after vs. 24&#x2005;h after (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05&#x002A;);<break/>- Adults&#x2009;&#x003E;&#x2009;Adolescents in Pre &#x0026; 24&#x2005;h after (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05&#x002A;).</td>
<td valign="top" align="left">Adults showed stronger increases in IL-6 after and 24&#x2005;h (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05&#x002A;).</td>
</tr>
<tr>
<td valign="top" align="left">IL8</td>
<td valign="top" align="left">- Time (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;205.9, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;);<break/>- Age group (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;2.50, df&#x2009;&#x003D;&#x2009;1, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.114);<break/>- Time&#x2009;&#x00D7;&#x2009;Age group (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;8.5, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.036&#x002A;).</td>
<td valign="top" align="left">- 2&#x2005;h vs. 24h: <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.072 [0.008&#x2013;0.136], SE&#x2009;&#x003D;&#x2009;0.033, <italic>z</italic>&#x2009;&#x003D;&#x2009;2.19, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.028&#x002A;;<break/>- Immediately after vs. 24h: <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.331 [0.267&#x2013;0.395], SE&#x2009;&#x003D;&#x2009;0.033, <italic>z</italic>&#x2009;&#x003D;&#x2009;10.14, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;;<break/>- Pre vs. 24h: <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.389 [0.325&#x2013;0.453], SE&#x2009;&#x003D;&#x2009;0.033, <italic>z</italic>&#x2009;&#x003D;&#x2009;11.93, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;.</td>
<td valign="top" align="left">- All time points &#x003E;24&#x2005;h (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;);<break/>- Adults&#x2009;&#x003E;&#x2009;Adolescents (Pre &#x0026; Immediately after).</td>
<td valign="top" align="left">Adults had higher IL-8 levels pre- and immediately after RSE (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05&#x002A;).</td>
</tr>
<tr>
<td valign="top" align="left">IL10</td>
<td valign="top" align="left">- Time (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;1.139, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.767);<break/>- Age group (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;3.94, df&#x2009;&#x003D;&#x2009;1, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.047&#x002A;);<break/>- Time&#x2009;&#x00D7;&#x2009;Age group (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;23.493, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;).</td>
<td valign="top" align="left">- Time (2&#x2005;h vs. 24&#x2005;h): <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.0887 [0.04785&#x2013;0.12954], SE&#x2009;&#x003D;&#x2009;0.0208, <italic>z</italic>&#x2009;&#x003D;&#x2009;4.2560, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;;<break/>- Time (Immediately After vs. 24&#x2005;h): <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;0.1088 [0.06792&#x2013;0.14963], SE&#x2009;&#x003D;&#x2009;0.0208, <italic>z</italic>&#x2009;&#x003D;&#x2009;5.2181, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;;<break/>- Age group (Adult - Adolescent): <italic>&#x03B2;</italic>&#x2009;&#x003D;&#x2009;&#x2212;0.1482 [&#x2212;0.29459&#x2013; &#x2212;0.00188], SE&#x2009;&#x003D;&#x2009;0.0747, <italic>z</italic>&#x2009;&#x003D;&#x2009;&#x2212;1.9852, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.047&#x002A;.</td>
<td valign="top" align="left">- Adults: 2&#x2005;h vs. 24&#x2005;h (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;);<break/>- Immediately After vs. 24&#x2005;h (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;);<break/>- Pre vs. Immediately After (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;).</td>
<td valign="top" align="left">- Adults: significant time effects (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;20.08, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001&#x002A;);<break/>- Adolescents: no significant time effects (&#x03C7;<sup>2</sup>&#x2009;&#x003D;&#x2009;3.46, df&#x2009;&#x003D;&#x2009;3, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.326).</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5"><p>IL, interleukyn; FFM, fat-free mass; &#x2191;, increase; &#x003E;, greater than; Group age, analysis of biological maturation when comparing adolescents [subjects in the process of maturation] with adults [biologically mature subjects].</p></fn>
</table-wrap-foot>
</table-wrap>
<p>For IL-6, there was a main effect of time and a significant Time&#x2009;&#x00D7;&#x2009;Age group interaction. <italic>Post hoc</italic> analyses showed that, in adults, IL-6 levels were significantly elevated immediately after exercise and 2&#x2005;h later compared to the 24&#x2005;h time point. Fixed effect estimates also indicated that adults had higher IL-6 levels than adolescents at the immediately after exercise and 24&#x2005;h time points. FFM and DII were also significant predictors for this cytokine, with the effects applying to both groups.</p>
<p>IL-8 presented a strong time effect and a significant Time&#x2009;&#x00D7;&#x2009;Age group interaction. IL-8 levels were consistently higher at all pre and immediately after exercise time points compared to the 24&#x2005;h time point, indicating a robust response to the effort. The interaction suggests that adults have consistently higher IL-8 levels before and after RSE compared to adolescents.</p>
<p>Finally, IL-10 did not show a main effect of time, but it did demonstrate a highly significant Time&#x2009;&#x00D7;&#x2009;Age group interaction. While adolescents showed no significant changes in IL-10 levels over time, adults exhibited a remarkable increase, with significantly higher levels 2&#x2005;h and immediately after RSE compared to 24&#x2005;h. This finding suggests that the anti-inflammatory response mediated by IL-10 is more effectively and acutely activated in adults in response to resistance exercise than in adolescents.</p>
</sec>
<sec id="s5" sec-type="discussion"><title>Discussion</title>
<p>This study investigated the influence of FFM, BM, and the DII on cytokine responses to a repeated sprint exercise (RSE) protocol in male athletes. The findings revealed distinct associations between adolescent and adult groups, suggesting that the after exercise inflammatory profile appears to be modulated by FFM levels, BM stage, and dietary patterns.</p>
<sec id="s5a"><title>Inflammatory responses and fat-free mass</title>
<p>The results of this study demonstrate that FFM plays a crucial role in immunoregulation, as reflected in the modulation of cytokine levels in response to exercise (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>). Both group comparisons (<xref ref-type="fig" rid="F2">Figures&#x00A0;2</xref>, <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="table" rid="T3">Table&#x00A0;3</xref>) and correlation analyses (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>) indicate that individuals with higher FFM exhibit elevated IL-6 levels at rest and immediately after RSE. These findings may be attributed to the endocrine function of muscle tissue, which releases IL-6 in response to mechanical and metabolic stress (<xref ref-type="bibr" rid="B2">2</xref>). However, the negative correlation between FFM and IL-10 observed in adults (pre, 2&#x2005;h, and 24&#x2005;h after RSE) deserves special attention. Although IL-10 is classically considered an anti-inflammatory cytokine, its reduction in individuals with higher FFM may suggest a distinct immunological adaptation in adult athletes, in which there is a greater demand for acute inflammatory responses at the expense of chronic anti-inflammatory modulation. This hypothesis warrants further investigation (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>During adolescence, the growth and maturation of muscle tissue may influence inflammatory responses (<xref ref-type="bibr" rid="B14">14</xref>). This may serve as a metabolic adaptation and repair mechanism, which could explain why adolescents with higher FFM showed negative correlations with IL-6 and IL-8 at 24&#x2005;h after RSE (<xref ref-type="table" rid="T1">Tables&#x00A0;1</xref>, <xref ref-type="table" rid="T3">3</xref>), suggesting a more efficient inflammatory recovery (<xref ref-type="bibr" rid="B4">4</xref>). IL-8, a cytokine associated with neutrophil recruitment and maintenance of the inflammatory response (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B50">50</xref>), may have been downregulated to prevent a prolonged inflammatory state in better-conditioned athletes (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>).</p>
<p>In contrast, adolescents with lower FFM showed a greater percent increase (&#x0394;&#x0025;) in IL-6 at 24&#x2005;h after RSE compared to their peers (<xref ref-type="fig" rid="F2">Figure&#x00A0;2B</xref>), suggesting that lower muscle reserves may compromise repair mechanisms and prolong the inflammatory response (<xref ref-type="bibr" rid="B2">2</xref>). Among adults, those with higher FFM consistently exhibited lower IL-10 levels (pre, 2&#x2005;h, and 24&#x2005;h after RSE) and a positive association between FFM and IL-6 at 2&#x2005;h after RSE (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>), reinforcing the importance of additional regulatory mechanisms in the modulation of the inflammatory response (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). It is worth noting that the absence of significant correlations between FFM and IL-1&#x03B2; in adolescents may indicate that this cytokine is less sensitive to variations in body composition at this age or that other factors (e.g., training load or nutritional status) exert a greater influence (<xref ref-type="table" rid="T1">Tables&#x00A0;1</xref>, <xref ref-type="table" rid="T3">3</xref>) (<xref ref-type="bibr" rid="B53">53</xref>).</p>
</sec>
<sec id="s5b"><title>Inflammatory profile and biological maturation</title>
<p>When controlling for BM (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>), a positive association was observed between FFM and IL-10 levels, suggesting that adolescents with higher FFM may present an anti-inflammatory predisposition, regardless of maturation stage. This adjustment also revealed a similar correlation for IL-6 levels, indicating that individuals with more muscle mass exhibit an acute IL-6 response to exercise, reinforcing the role of muscle tissue as a potential source of this cytokine (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>) (<xref ref-type="bibr" rid="B1">1</xref>). In this context, the inverse correlation with IL-1&#x03B2; at 24&#x2005;h after RSE in adolescents suggests that FFM may attenuate late inflammatory responses, possibly due to greater tissue repair capacity (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B53">53</xref>).</p>
<p>Consistently, less mature adolescents showed a greater percent increase (&#x0394;&#x0025;) in IL-6 at 24&#x2005;h after RSE compared to their more mature peers (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>), suggesting that inflammatory markers may be influenced by BM (<xref ref-type="bibr" rid="B10">10</xref>), possibly due to a still developing physiological system (<xref ref-type="bibr" rid="B14">14</xref>). Less mature individuals also tend to have lower FFM levels compared to their more biologically advanced peers (<xref ref-type="bibr" rid="B54">54</xref>), which may explain the similarity of findings when adolescents were grouped by FFM levels and BM status (<xref ref-type="fig" rid="F2">Figures&#x00A0;2B</xref>, <xref ref-type="fig" rid="F3">3B</xref>). These findings may not be exclusively linked to lower FFM, but also to hormonal variations (e.g., testosterone and GH) that influence both muscle development and immune activity (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>Furthermore, adolescents with higher FFM appeared to exhibit lower IL-1&#x03B2; levels at 24&#x2005;h after RSE (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). IL-1&#x03B2; is a pro-inflammatory cytokine involved in initiating the inflammatory response and muscle soreness (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B53">53</xref>). Lower concentrations at 24&#x2005;h after RSE in individuals with higher FFM may indicate a more controlled inflammatory response and more efficient recovery, potentially associated with training-induced adaptations and greater anti-inflammatory capacity (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>).</p>
</sec>
<sec id="s5c"><title>Inflammation and DII</title>
<p>The results of this study demonstrate that DII significantly influenced cytokine responses following RSE (<xref ref-type="fig" rid="F4">Figures&#x00A0;4C,H</xref>). Specifically, lower DII scores (indicating a more anti-inflammatory dietary pattern) were associated with higher IL-8 levels in adolescents and higher IL-10 levels in adults. These findings align with literature showing an inverse relationship between anti-inflammatory diets and pro-inflammatory markers such as IL-1&#x03B2;, IL-6, IL-8, TNF-&#x03B1;, and C-reactive protein (CRP) (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). The production of pro-inflammatory interleukins by muscle tissues during exercise is well documented and is considered an adaptive response that triggers anti-inflammatory pathways, mobilizes glycogen, and promotes metabolic adaptations (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>Among adults with higher FFM and anti-inflammatory dietary patterns, the observed increase in IL-10 after exercise may reflect enhanced anti-inflammatory responses. This aligns with previous evidence that IL-6 induces IL-10 and IL-1ra, modulating the inflammatory cascade (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Individuals with less inflammatory dietary patterns tend to present a more favorable redox and immune basal state, facilitating effective immune responses to physical stress (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B58">58</xref>&#x2013;<xref ref-type="bibr" rid="B61">61</xref>).</p>
<p>Individuals with less inflammatory dietary patterns tend to present a more favorable redox and immune basal state, facilitating effective immune responses to physical stress (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B61">61</xref>). The DII reflects the inflammatory potential of various macronutrients and micronutrients, which directly affect cytokine levels (<xref ref-type="bibr" rid="B41">41</xref>). Diets rich in saturated fats, refined sugars, and low in fiber are associated with higher IL-6, IL-8, CRP, and TNF-&#x03B1;, whereas diets rich in fruits, vegetables, and omega-3 fatty acids promote anti-inflammatory responses, including IL-10 (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B60">60</xref>).</p>
<p>Although the exact mechanisms remain to be clarified, it is presumed that an anti-inflammatory dietary pattern contributes to redox balance, reduced baseline expression of nuclear factor kappa B (NF-<italic>&#x03BA;</italic>B), and lower secretion of pro-inflammatory adipokines (e.g., TNF-&#x03B1;, IL-1&#x03B2;), thereby enabling a rapid and transient IL-6 response to exercise without prolonged inflammation (<xref ref-type="bibr" rid="B62">62</xref>&#x2013;<xref ref-type="bibr" rid="B64">64</xref>). During the recovery phase, the modulatory effect of DII is manifested through more efficient IL-10 expression, aiding inflammation resolution.</p>
</sec>
<sec id="s5d"><title>Practical applications: insights for training load control</title>
<p>The findings of this study provide relevant insights for training load management, particularly in adolescent and adult athletes involved in intermittent sports. The observation that individuals with lower FFM exhibit greater inflammatory variation (especially IL-6 at 24&#x2005;h after RSE) suggests a slower inflammatory recovery and a potentially higher risk of immune overload. This implies that athletes with lower muscle development may require longer recovery intervals between high-intensity sessions or complementary interventions (e.g., nutritional and sleep strategies) that support inflammation resolution.</p>
<p>In adolescents, the influence of BM on inflammatory responses reinforces the need to individualize training loads according to maturation status. Biologically less mature athletes showed more prolonged inflammatory responses (<xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>), which may hinder training adaptations. Monitoring PHV status, skeletal maturation, and puberty stages can help coaches and strength professionals avoid overloading immature athletes, promoting safer and more sustainable development.</p>
<p>In adults, greater FFM was associated with more effective IL-10 modulation, indicating a more favorable anti-inflammatory profile and enhanced recovery potential. This information may assist in adjusting training load based on athletes&#x0027; morphological status, as individuals with higher FFM may tolerate greater volumes and intensities with lower risk of chronic inflammation.</p>
<p>Finally, the DII emerges as a practical and promising tool for sports science. Our findings indicate that dietary patterns with lower inflammatory potential (as reflected in lower DII values) are associated with more efficient immune responses to exercise, particularly in adults with higher FFM (greater IL-10) and adolescents (lower IL-8) (<xref ref-type="fig" rid="F4">Figures&#x00A0;4C,H</xref>). This reinforces the need to incorporate regular nutritional assessments into training load monitoring. Nutritional intervention programs focused on healthy and anti-inflammatory diets, aimed at reducing DII, may serve as important complementary strategies. This nutritional approach seeks to reduce exercise-induced immune overload, optimizing recovery and sports performance across age groups and maturation stages.</p>
</sec>
<sec id="s5e"><title>Limitations and future directions</title>
<p>Despite its relevant findings, the present study presents the following limitations: (i) Only athletes from intermittent sports were included, requiring caution when generalizing the findings to endurance sports; (ii) Only male athletes were analyzed, and extrapolation to female athletes should be made with caution; (iii) Although intragroup comparisons, statistical corrections, <italic>post hoc</italic> power analyses, and control for interaction variables (FFM, BM, and DII) were performed, caution is warranted when interpreting the results of the adult group due to the small sample size. We note that while the sample size and group imbalance are considerable limitations, the statistical methodology employed (GLMM) was chosen to minimize the impact of these factors, thereby increasing the internal validity of the results with the observation of 120 events when considering the time points (pre, immediately after, 2&#x2005;h, and 24&#x2005;h after RSE); (iv) Finally, a limitation to be considered is the absence of a control group for the RSE protocol; however, the repeated-measures design, combined with the GLMM analysis, allowed each participant to serve as their own control, strengthening the study&#x0027;s internal validity.</p>
<p>Future studies should seek to address the limitations outlined in this section.</p>
</sec>
</sec>
<sec id="s6" sec-type="conclusions"><title>Conclusion</title>
<p>This study concludes that FFM, BM, and the DII significantly influence the inflammatory response to repeated sprint exercise (RSE) in male athletes. In adolescents, BM appears to modulate the interaction between FFM and interleukin dynamics after intense exercise. Lower FFM levels were associated with a more pronounced and prolonged IL-6 response, indicating a potentially greater risk of immune overload and the need for more cautious recovery strategies. In adults, greater FFM was linked to a more robust IL-10 response, suggesting a more efficient anti-inflammatory profile. DII, in turn, independently modulated the immune response, with less inflammatory dietary patterns associated with cytokines that favor recovery (e.g., IL-10).</p>
<p>These findings highlight the importance of an integrated approach to training load management that considers not only body composition and BM, but also athletes&#x0027; dietary patterns. The incorporation of DII as a nutritional monitoring tool may represent a strategic advancement in the personalization of training and the promotion of safe and effective immunometabolic adaptations. It is recommended that strength and conditioning coaches, sports scientists, and nutritionists adopt a multidimensional approach that include regular assessments of FFM, BM, and DII in training and recovery planning. Integrating these markers into evaluation and planning processes may significantly enhance the personalization of sports interventions, contributing to athletes&#x0027; health, performance, and long-term development.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability"><title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <ext-link ext-link-type="uri" xlink:href="https://figshare.com/articles/dataset/Raw_Data_-_Cytokines_DII_FFM_BM_Sprints_/29506262">https://figshare.com/articles/dataset/Raw_Data_-_Cytokines_DII_FFM_BM_Sprints_/29506262</ext-link>.</p>
</sec>
<sec id="s8" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of the Federal University of Rio Grande do Norte (&#x0023;35197020.8.0000.5537). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x0027; legal guardians/next of kin.</p>
</sec>
<sec id="s9" sec-type="author-contributions"><title>Author contributions</title>
<p>PA-N: Writing &#x2013; review &#x0026; editing, Investigation, Conceptualization, Validation, Methodology, Writing &#x2013; original draft, Formal analysis, Visualization, Data curation. EF: Data curation, Validation, Investigation, Methodology, Writing &#x2013; review &#x0026; editing, Formal analysis, Writing &#x2013; original draft, Visualization. GA: Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft, Resources, Visualization, Validation. KS: Writing &#x2013; review &#x0026; editing, Resources, Visualization, Validation, Supervision. RC: Writing &#x2013; review &#x0026; editing, Visualization, Resources, Validation. LA: Validation, Writing &#x2013; review &#x0026; editing, Visualization, Software, Resources. VP: Supervision, Methodology, Validation, Writing &#x2013; original draft. FA: Supervision, Methodology, Validation, Writing &#x2013; original draft, Conceptualization, Visualization. BC: Conceptualization, Project administration, Supervision, Validation, Methodology, Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft, Resources, Visualization, Investigation. PD: Software, Resources, Writing &#x2013; original draft, Investigation, Visualization, Validation, Formal analysis, Data curation, Supervision, Conceptualization, Writing &#x2013; review &#x0026; editing, Project administration, Methodology.</p>
</sec>
<sec id="s10" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. PA-N receives a doctoral scholarship from the National Council for Scientific Development (CNPQ) (Process: &#x0023;157144/2021-6).</p>
</sec>
<ack><title>Acknowledgments</title>
<p>For support and encouragement for the development of this academic article, we thank the Federal University of Rio Grande do Norte (UFRN), the Physical Activity and Health (AFISA) research base, the Sports and Human Performance Research Group (GPEDEH), the Dalton Cunha blood center in the city of Natal/Brazil. The National Council for Scientific Development (CNPQ) and the Higher Education Personnel Improvement Coordination (CAPES).</p>
</ack>
<sec id="s11" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s14" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fspor.2025.1662761/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fspor.2025.1662761/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material id="SD1" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="Table1.xlsx"/></supplementary-material>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr" id="ab001"><p>RSE, repeated sprint exercise; BM, biological maturation; PHV, peak height velocity; IPAQ, international physical active questionnaire; MET&#x0027;s, metabolic equivalents; RPE, rate of perceived exertion; URTI, upper respiratory tract infection; WURSS-21, Wisconsin upper respiratory symptom survey-21; DXA, dual-energy x-ray absorptiometry; &#x0394;, delta coefficient; DII, dietary inflammatory index; FFM, fat-free mass.</p></fn>
</fn-group>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ringleb</surname><given-names>M</given-names></name><name><surname>Javelle</surname><given-names>F</given-names></name><name><surname>Haunhorst</surname><given-names>S</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name><name><surname>Fennen</surname><given-names>L</given-names></name><name><surname>Baumgart</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Beyond muscles: investigating immunoregulatory myokines in acute resistance exercise&#x2013;A systematic review and meta-analysis</article-title>. <source>FASEB J</source>. (<year>2024</year>) <volume>38</volume>:<fpage>e23596</fpage>. <pub-id pub-id-type="doi">10.1096/fj.202301619R</pub-id><pub-id pub-id-type="pmid">38597350</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Severinsen</surname><given-names>MCK</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group>. <article-title>Muscle&#x2013;organ crosstalk: the emerging roles of myokines</article-title>. <source>Endocr Rev</source>. (<year>2020</year>) <volume>41</volume>:<fpage>594</fpage>&#x2013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1210/endrev/bnaa016</pub-id><pub-id pub-id-type="pmid">32393961</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Hekmatikar</surname><given-names>AHA</given-names></name><name><surname>Jalalian</surname><given-names>S</given-names></name><name><surname>Abbasi</surname><given-names>S</given-names></name><name><surname>Ahmadi</surname><given-names>E</given-names></name><name><surname>Kazemi</surname><given-names>A</given-names></name><etal/></person-group> <article-title>The potential of exerkines in women&#x2019;s COVID-19: a new idea for a better and more accurate understanding of the mechanisms behind physical exercise</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2022</year>) <volume>19</volume>:<fpage>15645</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph192315645</pub-id><pub-id pub-id-type="pmid">36497720</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aliyu</surname><given-names>M</given-names></name><name><surname>Zohora</surname><given-names>FT</given-names></name><name><surname>Anka</surname><given-names>AU</given-names></name><name><surname>Ali</surname><given-names>K</given-names></name><name><surname>Maleknia</surname><given-names>S</given-names></name><name><surname>Saffarioun</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach</article-title>. <source>Int Immunopharmacol</source>. (<year>2022</year>) <volume>111</volume>:<fpage>109130</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2022.109130</pub-id><pub-id pub-id-type="pmid">35969896</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saraiva</surname><given-names>M</given-names></name><name><surname>Vieira</surname><given-names>P</given-names></name><name><surname>O&#x2019;garra</surname><given-names>A</given-names></name></person-group>. <article-title>Biology and therapeutic potential of interleukin-10</article-title>. <source>J Exp Med</source>. (<year>2019</year>) <volume>217</volume>:<fpage>e20190418</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20190418</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname><given-names>R</given-names></name><name><surname>Lyons</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>AJ</given-names></name><name><surname>Kenny</surname><given-names>IC</given-names></name></person-group>. <article-title>Sprinting performance and resistance-based training interventions: a systematic review</article-title>. <source>The J Strength Cond Res</source>. (<year>2015</year>) <volume>29</volume>:<fpage>1146</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1519/JSC.0000000000000720</pub-id><pub-id pub-id-type="pmid">25268287</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>D</given-names></name><name><surname>Girard</surname><given-names>O</given-names></name><name><surname>Mendez-Villanueva</surname><given-names>A</given-names></name></person-group>. <article-title>Repeated-sprint ability&#x2014;part II: recommendations for training</article-title>. <source>Sports Med</source>. (<year>2011</year>) <volume>41</volume>:<fpage>741</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.2165/11590560-000000000-00000</pub-id><pub-id pub-id-type="pmid">21846163</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Almeida-Neto</surname><given-names>PF</given-names></name><name><surname>Wilde</surname><given-names>P</given-names></name><name><surname>de Assis</surname><given-names>GG</given-names></name><name><surname>Wola&#x0144;ski</surname><given-names>P</given-names></name><name><surname>de Oliveira</surname><given-names>FCS</given-names></name><name><surname>Martins</surname><given-names>RE</given-names></name><etal/></person-group> <article-title>Leukocyte response to repeated sprint exercise: differences between adolescent and adult athletes</article-title>. <source>Sports Med Health Sci</source>. (<year>2025</year>). <pub-id pub-id-type="doi">10.1016/j.smhs.2025.05.003</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>D</given-names></name><name><surname>Vale</surname><given-names>AF</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>Ara&#x00FA;jo</surname><given-names>MAS</given-names></name><name><surname>de Paula J&#x00FA;nior</surname><given-names>CA</given-names></name><name><surname>de Lira</surname><given-names>CAB</given-names></name><etal/></person-group> <article-title>Acute and chronic effects of interval training on the immune system: a systematic review with meta-analysis</article-title>. <source>Biology (Basel)</source>. (<year>2021</year>) <volume>10</volume>:<fpage>868</fpage>. <pub-id pub-id-type="doi">10.3390/biology10090868</pub-id><pub-id pub-id-type="pmid">34571745</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>F</given-names></name><name><surname>Almeida-Neto</surname><given-names>P</given-names></name><name><surname>J&#x00FA;nior</surname><given-names>GBC</given-names></name><name><surname>Ururahy</surname><given-names>MAG</given-names></name><name><surname>Dantas</surname><given-names>MA</given-names></name><name><surname>Cabral</surname><given-names>BGDAT</given-names></name><etal/></person-group> <article-title>Influence of repeated sprint exercise on leukocyte morphology in adolescent athletes at different biological maturation rates</article-title>. <source>Front Physiol</source>. (<year>2025</year>) <volume>16</volume>:<fpage>1480776</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2025.1480776</pub-id><pub-id pub-id-type="pmid">40110185</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name></person-group>. <article-title>Characterization of exercise-induced cytokine release, the impacts on the body, the mechanisms and modulations</article-title>. <source>Int J Sports Exerc Med</source>. (<year>2019</year>) <volume>5</volume>:<fpage>10</fpage>&#x2013;<lpage>23937</lpage>. <pub-id pub-id-type="doi">10.23937/2469-5718/1510122</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buchheit</surname><given-names>M</given-names></name><name><surname>Laursen</surname><given-names>PB</given-names></name></person-group>. <article-title>High-intensity interval training, solutions to the programming puzzle: part I: cardiopulmonary emphasis</article-title>. <source>Sports Med</source>. (<year>2013</year>) <volume>43</volume>:<fpage>313</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-013-0029-x</pub-id><pub-id pub-id-type="pmid">23539308</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buchheit</surname><given-names>M</given-names></name><name><surname>Laursen</surname><given-names>PB</given-names></name></person-group>. <article-title>High-intensity interval training, solutions to the programming puzzle. Part II: anaerobic energy, neuromuscular load and practical applications</article-title>. <source>Sports Med</source>. (<year>2013</year>) <volume>43</volume>:<fpage>927</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-013-0066-5</pub-id><pub-id pub-id-type="pmid">23832851</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Almeida-Neto</surname><given-names>PF</given-names></name><name><surname>de Medeiros</surname><given-names>JA</given-names></name><name><surname>Jaggers</surname><given-names>JR</given-names></name><name><surname>Ferreira</surname><given-names>ABdM</given-names></name><name><surname>de Assis</surname><given-names>GG</given-names></name><name><surname>Cabral</surname><given-names>BGdAT</given-names></name><etal/></person-group> <article-title>Exercise immunology applied to pediatric sport and the importance of monitoring stages of puberty and biological maturation</article-title>. <source>Sports Health</source>. (<year>2023</year>) <volume>17</volume>(<issue>1</issue>):<fpage>46</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1177/19417381231212481</pub-id><pub-id pub-id-type="pmid">37997928</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grosso</surname><given-names>G</given-names></name><name><surname>Laudisio</surname><given-names>D</given-names></name><name><surname>Frias-Toral</surname><given-names>E</given-names></name><name><surname>Barrea</surname><given-names>L</given-names></name><name><surname>Muscogiuri</surname><given-names>G</given-names></name><name><surname>Savastano</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Anti-inflammatory nutrients and obesity-associated metabolic-inflammation: state of the art and future direction</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>1137</fpage>. <pub-id pub-id-type="doi">10.3390/nu14061137</pub-id><pub-id pub-id-type="pmid">35334794</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Almeida-Neto</surname><given-names>PF</given-names></name><name><surname>de Medeiros</surname><given-names>RCDSC</given-names></name><name><surname>de Matos</surname><given-names>DG</given-names></name><name><surname>Baxter-Jones</surname><given-names>ADG</given-names></name><name><surname>Aidar</surname><given-names>FJ</given-names></name><name><surname>de Assis</surname><given-names>GG</given-names></name><etal/></person-group> <article-title>Lean mass and biological maturation as predictors of muscle power and strength performance in young athletes</article-title>. <source>PLoS One</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0254552</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0254552</pub-id><pub-id pub-id-type="pmid">34252161</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makowski</surname><given-names>D</given-names></name><name><surname>Ben-Shachar</surname><given-names>MS</given-names></name><name><surname>Patil</surname><given-names>I</given-names></name><name><surname>L&#x00FC;decke</surname><given-names>D</given-names></name></person-group>. <article-title>Methods and algorithms for correlation analysis in R</article-title>. <source>J Open Source Softw</source>. (<year>2020</year>) <volume>5</volume>:<fpage>2306</fpage>. <pub-id pub-id-type="doi">10.21105/joss.02306</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khammar</surname><given-names>A</given-names></name><name><surname>Yarahmadi</surname><given-names>M</given-names></name><name><surname>Madadizadeh</surname><given-names>F</given-names></name></person-group>. <article-title>What is analysis of covariance (ANCOVA) and how to correctly report its results in medical research?</article-title> <source>Iran J Public Health</source>. (<year>2020</year>) <volume>49</volume>:<fpage>1016</fpage>.<pub-id pub-id-type="pmid">32953697</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fayh</surname><given-names>APT</given-names></name><name><surname>de Sousa</surname><given-names>IM</given-names></name><name><surname>Gonzalez</surname><given-names>MC</given-names></name></person-group>. <article-title>New insights on how and where to measure muscle mass</article-title>. <source>Curr Opin Support Palliat Care</source>. (<year>2020</year>) <volume>14</volume>:<fpage>316</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1097/SPC.0000000000000524</pub-id><pub-id pub-id-type="pmid">33009007</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>S</given-names></name><name><surname>Hosseinikia</surname><given-names>M</given-names></name><name><surname>Ghaffarian-Bahraman</surname><given-names>A</given-names></name><name><surname>Clark</surname><given-names>CCT</given-names></name><name><surname>Davies</surname><given-names>IG</given-names></name><name><surname>Yousefi Rad</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Dietary inflammatory index and elevated serum C-reactive protein: a systematic review and meta-analysis</article-title>. <source>Food Sci Nutr</source>. (<year>2023</year>) <volume>11</volume>:<fpage>5786</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1002/fsn3.3553</pub-id><pub-id pub-id-type="pmid">37823095</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Almeida-Neto</surname><given-names>PF</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Wilde</surname><given-names>P</given-names></name><name><surname>Bahia</surname><given-names>IAF</given-names></name><name><surname>de Farias Sales</surname><given-names>VS</given-names></name><name><surname>Cavalcanti J&#x00FA;nior</surname><given-names>GB</given-names></name><etal/></person-group> <article-title>Effect of repeated sprint exercise on immunological responses in adult and adolescent athletes at different stages of biological maturation: a-quasi-experimental-trial</article-title>. <source>Sci Rep</source>. (<year>2025</year>) <volume>15</volume>:<fpage>28471</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-025-13515-0</pub-id><pub-id pub-id-type="pmid">40760148</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>ALMA</given-names></name></person-group>. <source>Associa&#x00E7;&#x00E3;o do &#x00CD;ndice Inflamat&#x00F3;rio da dieta e Fatores Sociodemogr&#x00E1;ficos Com o Risco cardiovascular: Estudo</source>. <publisher-loc>Natal</publisher-loc>: <publisher-name>Brazuca Natal</publisher-name> (<year>2023</year>).</citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>AKA</given-names></name><name><surname>Stellingwerff</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>ES</given-names></name><name><surname>Martin</surname><given-names>DT</given-names></name><name><surname>Mujika</surname><given-names>I</given-names></name><name><surname>Goosey-Tolfrey</surname><given-names>VL</given-names></name><etal/></person-group> <article-title>Defining training and performance caliber: a participant classification framework</article-title>. <source>Int J Sports Physiol Perform</source>. (<year>2021</year>) <volume>17</volume>:<fpage>317</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1123/ijspp.2021-0451</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>VS</given-names></name><name><surname>Vieira</surname><given-names>MFS</given-names></name></person-group>. <article-title>International society for the advancement of kinanthropometry (ISAK) global: international accreditation scheme of the competent anthropometrist</article-title>. <source>Rev Bras Cineantropom Desempenho Hum</source>. (<year>2020</year>) <volume>22</volume>:<fpage>e70517</fpage>. <pub-id pub-id-type="doi">10.1590/1980-0037.2020v22e70517</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perini</surname><given-names>TA</given-names></name><name><surname>de Oliveira</surname><given-names>GL</given-names></name><name><surname>Ornellas</surname><given-names>JDS</given-names></name><name><surname>de Oliveira</surname><given-names>FP</given-names></name></person-group>. <article-title>Technical error of measurement in anthropometry</article-title>. <source>Rev Bras Med Esporte</source>. (<year>2005</year>) <volume>11</volume>:<fpage>81</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1590/S1517-86922005000100009</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khadilkar</surname><given-names>A</given-names></name><name><surname>Chiplonkar</surname><given-names>S</given-names></name><name><surname>Sanwalka</surname><given-names>N</given-names></name><name><surname>Khadilkar</surname><given-names>V</given-names></name><name><surname>Mandlik</surname><given-names>R</given-names></name><name><surname>Ekbote</surname><given-names>V</given-names></name></person-group>. <article-title>A cross-calibration study of GE lunar iDXA and GE lunar DPX pro for body composition measurements in children and adults</article-title>. <source>J Clin Densitom</source>. (<year>2020</year>) <volume>23</volume>:<fpage>128</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocd.2019.03.003</pub-id><pub-id pub-id-type="pmid">30981615</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>SA</given-names></name><name><surname>McKay</surname><given-names>HA</given-names></name><name><surname>Macdonald</surname><given-names>H</given-names></name><name><surname>Nettlefold</surname><given-names>L</given-names></name><name><surname>Baxter-Jones</surname><given-names>ADG</given-names></name><name><surname>Cameron</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Enhancing a somatic maturity prediction model</article-title>. <source>Med Sci Sports Exerc</source>. (<year>2015</year>) <volume>47</volume>:<fpage>1755</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0000000000000588</pub-id><pub-id pub-id-type="pmid">25423445</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Almeida-Neto</surname><given-names>PF</given-names></name><name><surname>Baxter-Jones</surname><given-names>ADG</given-names></name><name><surname>Arrais</surname><given-names>RF</given-names></name><name><surname>de Azevedo</surname><given-names>JCV</given-names></name><name><surname>Dantas</surname><given-names>PMS</given-names></name><name><surname>Cabral</surname><given-names>BGdAT</given-names></name><etal/></person-group> <article-title>Enhancement of a mathematical model for predicting puberty stage in boys: a cross-sectional study</article-title>. <source>Am J Hum Biol</source>. (<year>2025</year>) <volume>37</volume>:<fpage>e24193</fpage>. <pub-id pub-id-type="doi">10.1002/ajhb.24193</pub-id><pub-id pub-id-type="pmid">39584193</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabral</surname><given-names>BGDAT</given-names></name><name><surname>de Cabral</surname><given-names>SAT</given-names></name><name><surname>Vital</surname><given-names>R</given-names></name><name><surname>de Lima</surname><given-names>KC</given-names></name><name><surname>Alcantara</surname><given-names>T</given-names></name><name><surname>Reis</surname><given-names>VM</given-names></name><etal/></person-group> <article-title>Prediction equation of bone age in sports initiation through anthropometric variables</article-title>. <source>Rev Bras Med Esporte</source>. (<year>2013</year>) <volume>19</volume>:<fpage>99</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1590/S1517-86922013000200005</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Malina</surname><given-names>RM</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name></person-group>. <source>Physical Activity of the Young Athlete: From Growth to Maturation</source>. <publisher-loc>S&#x00E3;o Paulo</publisher-loc>: <publisher-name>ROCA</publisher-name> (<year>2002</year>).</citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>RL</given-names></name><name><surname>Mundt</surname><given-names>MP</given-names></name><name><surname>Thomas</surname><given-names>GR</given-names></name><name><surname>Barlow</surname><given-names>SK</given-names></name><name><surname>Highstrom</surname><given-names>AD</given-names></name><etal/></person-group> <article-title>Validation of a short form Wisconsin upper respiratory symptom survey (WURSS-21)</article-title>. <source>Health Qual Life Outcomes</source>. (<year>2009</year>) <volume>7</volume>:<fpage>1</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1186/1477-7525-7-76</pub-id><pub-id pub-id-type="pmid">19134191</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>B</given-names></name><name><surname>Locken</surname><given-names>K</given-names></name><name><surname>Maberry</surname><given-names>R</given-names></name><name><surname>Schwamman</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><name><surname>Bobula</surname><given-names>J</given-names></name><etal/></person-group> <article-title>The Wisconsin upper respiratory symptom survey (WURSS): a new research instrument for assessing the common cold</article-title>. <source>J Fam Pract</source>. (<year>2002</year>) <volume>51</volume>:<fpage>265</fpage>. <comment>Available online at</comment>: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11978238/">https://pubmed.ncbi.nlm.nih.gov/11978238/</ext-link><pub-id pub-id-type="pmid">11978238</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmit</surname><given-names>KM</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><name><surname>Hayer</surname><given-names>S</given-names></name><name><surname>Checovich</surname><given-names>MM</given-names></name><name><surname>Gern</surname><given-names>JE</given-names></name><name><surname>Wald</surname><given-names>ER</given-names></name><etal/></person-group> <article-title>Wisconsin Upper respiratory symptom survey for kids: validation of an illness-specific quality of life instrument</article-title>. <source>Pediatr Res</source>. (<year>2021</year>) <volume>90</volume>:<fpage>1207</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/s41390-021-01395-9</pub-id><pub-id pub-id-type="pmid">33627821</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunelli</surname><given-names>DT</given-names></name><name><surname>Rodrigues</surname><given-names>A</given-names></name><name><surname>Lopes</surname><given-names>WA</given-names></name><name><surname>G&#x00E1;spari</surname><given-names>AF</given-names></name><name><surname>Bonganha</surname><given-names>V</given-names></name><name><surname>Montagner</surname><given-names>PC</given-names></name><etal/></person-group> <article-title>Monitoring of immunological parameters in adolescent basketball athletes during and after a sports season</article-title>. <source>J Sports Sci</source>. (<year>2014</year>) <volume>32</volume>:<fpage>1050</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/02640414.2013.878806</pub-id><pub-id pub-id-type="pmid">24479737</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>AAP</given-names></name><name><surname>Pires Junior</surname><given-names>R</given-names></name><name><surname>de Oliveira</surname><given-names>RF</given-names></name></person-group>. <article-title>Consistency between print and electronic IPAQ-L formats</article-title>. <source>Rev Bras Med Esporte</source>. (<year>2014</year>) <volume>20</volume>:<fpage>474</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1590/1517-86922014200602134</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>DL</given-names></name><name><surname>Sacco</surname><given-names>WP</given-names></name></person-group>. <article-title>Measuring sleep efficiency: what should the denominator be?</article-title> <source>J Clin Sleep Med</source>. (<year>2016</year>) <volume>12</volume>:<fpage>263</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.5664/jcsm.5498</pub-id><pub-id pub-id-type="pmid">26194727</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>RS</given-names></name></person-group>. <source>Principles of Nutritional Assessment</source>. <publisher-loc>USA</publisher-loc>: <publisher-name>Oxford University Press</publisher-name> (<year>2005</year>).</citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="book"><collab>Universidade de S&#x00E3;o Paulo (USP)</collab>. <source>Tabela Brasileira de Composi&#x00E7;&#x00E3;o de Alimentos (TBCA)</source>. <publisher-loc>S&#x00E3;o Paulo</publisher-loc>: <publisher-name>Food Research Center (FoRC)</publisher-name> (<year>2019</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="http://www.tbca.net.br/index.html">http://www.tbca.net.br/index.html</ext-link></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haubrock</surname><given-names>J</given-names></name><name><surname>N&#x00F6;thlings</surname><given-names>U</given-names></name><name><surname>Volatier</surname><given-names>J-L</given-names></name><name><surname>Dekkers</surname><given-names>A</given-names></name><name><surname>Ock&#x00E9;</surname><given-names>M</given-names></name><name><surname>Harttig</surname><given-names>U</given-names></name><etal/></person-group> <article-title>Estimating usual food intake distributions by using the multiple source method in the EPIC-Potsdam calibration study1&#x2013;3</article-title>. <source>J Nutr</source>. (<year>2011</year>) <volume>141</volume>:<fpage>914</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3945/jn.109.120394</pub-id><pub-id pub-id-type="pmid">21430241</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x00E9;bert</surname><given-names>JR</given-names></name><name><surname>Shivappa</surname><given-names>N</given-names></name><name><surname>Wirth</surname><given-names>MD</given-names></name><name><surname>Hussey</surname><given-names>JR</given-names></name><name><surname>Hurley</surname><given-names>TG</given-names></name></person-group>. <article-title>Perspective: the dietary inflammatory Index (DII)&#x2014;lessons learned, improvements made, and future directions</article-title>. <source>Adv Nutr</source>. (<year>2019</year>) <volume>10</volume>:<fpage>185</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1093/advances/nmy071</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shivappa</surname><given-names>N</given-names></name><name><surname>Steck</surname><given-names>SE</given-names></name><name><surname>Hurley</surname><given-names>TG</given-names></name><name><surname>Hussey</surname><given-names>JR</given-names></name><name><surname>H&#x00E9;bert</surname><given-names>JR</given-names></name></person-group>. <article-title>Designing and developing a literature-derived, population-based dietary inflammatory index</article-title>. <source>Public Health Nutr</source>. (<year>2014</year>) <volume>17</volume>:<fpage>1689</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1017/S1368980013002115</pub-id><pub-id pub-id-type="pmid">23941862</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>LET</given-names></name><name><surname>Waller</surname><given-names>MA</given-names></name><name><surname>van der Schouw</surname><given-names>YT</given-names></name><name><surname>Hebert</surname><given-names>JR</given-names></name><name><surname>Shivappa</surname><given-names>N</given-names></name><name><surname>Schoenaker</surname><given-names>DAJM</given-names></name><etal/></person-group> <article-title>The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: findings from an Australian population-based prospective cohort study of women</article-title>. <source>Atherosclerosis</source>. (<year>2016</year>) <volume>253</volume>:<fpage>164</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2016.07.929</pub-id><pub-id pub-id-type="pmid">27498398</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>GA</given-names></name></person-group>. <article-title>Psychophysical bases of perceived exertion</article-title>. <source>Med Sci Sports Exerc</source>. (<year>1982</year>) <volume>14</volume>:<fpage>377</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1249/00005768-198205000-00012</pub-id><pub-id pub-id-type="pmid">7154893</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>O&#x2019;Shea</surname><given-names>JJ</given-names></name><name><surname>Gadina</surname><given-names>M</given-names></name><name><surname>Siegel</surname><given-names>RM</given-names></name></person-group>. <article-title>Cytokines and cytokine receptors</article-title>. In: <person-group person-group-type="editor"><name><surname>Rich</surname><given-names>RR</given-names></name><name><surname>Fleisher</surname><given-names>TA</given-names></name><name><surname>Shearer</surname><given-names>WT</given-names></name><name><surname>Schroeder</surname><given-names>HW</given-names></name><name><surname>Frew</surname><given-names>AJ</given-names></name><name><surname>Weyand</surname><given-names>CM</given-names></name></person-group>, editors. <source>Clinical Immunology</source>. <edition>5th ed</edition>. <publisher-loc>Birmingham, AL</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2019</year>). p. <fpage>127</fpage>&#x2013;<lpage>55.e1</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-7020-6896-6.00009-0</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="book"><collab>Becton D, Company BD Life Sciences</collab>. <source>Instruction Manual: BD Cytometric Bead Array (CBA) Human Inflammatory Cytokines Kit [Internet], Catalog No. 551811. Vols. 23-11112-01 Rev. 03</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Becton, Dickinson and Company BD Life Sciences - Biosciences</publisher-name> (<year>2019</year>). p. <fpage>1</fpage>&#x2013;<lpage>52</lpage>.</citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="book"><comment>Becton, Dickinson and Company. BD cytometric bead array (CBA) human inflammatory cytokines kit: instruction manual (2019). Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.bdbiosciences.com/content/dam/bdb/products/global/reagents/immunoassay-reagents/cba/cba-kits/551xxx/5518xx/551811_base/pdf/551811_Book_Website.pdf">https://www.bdbiosciences.com/content/dam/bdb/products/global/reagents/immunoassay-reagents/cba/cba-kits/551xxx/5518xx/551811_base/pdf/551811_Book_Website.pdf</ext-link> <comment>(Accessed December 19, 2024).</comment></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rousselet</surname><given-names>G</given-names></name><name><surname>Pernet</surname><given-names>CR</given-names></name><name><surname>Wilcox</surname><given-names>RR</given-names></name></person-group>. <article-title>An introduction to the bootstrap: a versatile method to make inferences by using data-driven simulations</article-title>. <source>Meta-Psychology</source>. (<year>2023</year>) <volume>7</volume>:<fpage>MP.2019.2058</fpage>. <pub-id pub-id-type="doi">10.15626/MP.2019.2058</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schober</surname><given-names>P</given-names></name><name><surname>Boer</surname><given-names>C</given-names></name><name><surname>Schwarte</surname><given-names>LA</given-names></name></person-group>. <article-title>Correlation coefficients: appropriate use and interpretation</article-title>. <source>Anesth Analg</source>. (<year>2018</year>) <volume>126</volume>(<issue>5</issue>):<fpage>1763</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1213/ANE.0000000000002864</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerby</surname><given-names>DS</given-names></name></person-group>. <article-title>The simple difference formula: an approach to teaching nonparametric correlation</article-title>. <source>Compr Psychol</source>. (<year>2014</year>) <volume>3</volume>:<fpage>11-IT</fpage>. <pub-id pub-id-type="doi">10.2466/11.IT.3.1</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group>. <article-title>Quantitative methods in psychology: a power primer</article-title>. <source>Psychol Bull</source>. (<year>1992</year>) <volume>112</volume>:<fpage>1155</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1037/0033-2909.112.1.155</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Totsuka</surname><given-names>M</given-names></name><name><surname>Nakaji</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Kudoh</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group> <article-title>Endurance exercise causes interaction among stress hormones, cytokines, neutrophil dynamics, and muscle damage</article-title>. <source>J Appl Physiol</source>. (<year>1999</year>) <volume>87</volume>:<fpage>1360</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1999.87.4.1360</pub-id><pub-id pub-id-type="pmid">10517764</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name></person-group>. <article-title>Involvement of neutrophils in exercise-induced muscle damage and its modulation</article-title>. <source>Gen Intern Med Clin Innov</source>. (<year>2018</year>) <volume>3</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.15761/GIMCI.1000170</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mochizuki</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Nakaji</surname><given-names>S</given-names></name><name><surname>Sugawara</surname><given-names>K</given-names></name><name><surname>Totsuka</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name></person-group>. <article-title>Effects of maximal exercise on nonspecific immunity in athletes under trained and detrained conditions</article-title>. <source>Jpn J Phys Fitness Sports Med</source>. (<year>1999</year>) <volume>48</volume>:<fpage>147</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.7600/jspfsm1949.48.147</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K</given-names></name></person-group>. <article-title>Cytokine response to exercise and its modulation</article-title>. <source>Antioxidants</source>. (<year>2018</year>) <volume>7</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.3390/antiox7010017</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Almeida-Neto</surname><given-names>PF</given-names></name><name><surname>de Matos</surname><given-names>DG</given-names></name><name><surname>Pinto</surname><given-names>VCM</given-names></name><name><surname>Dantas</surname><given-names>PMS</given-names></name><name><surname>Ces&#x00E1;rio</surname><given-names>TM</given-names></name><name><surname>da Silva</surname><given-names>LF</given-names></name><etal/></person-group> <article-title>Can the neuromuscular performance of young athletes be influenced by hormone levels and different stages of puberty?</article-title> <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<fpage>5637</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17165637</pub-id><pub-id pub-id-type="pmid">32764284</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>BK</given-names></name><name><surname>Steensberg</surname><given-names>A</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>C</given-names></name><name><surname>Hiscock</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects</article-title>. <source>Pfl&#x00FC;gers Archiv</source>. (<year>2003</year>) <volume>446</volume>:<fpage>9</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-002-0981-z</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hennigar</surname><given-names>SR</given-names></name><name><surname>McClung</surname><given-names>JP</given-names></name><name><surname>Pasiakos</surname><given-names>SM</given-names></name></person-group>. <article-title>Nutritional interventions and the IL-6 response to exercise</article-title>. <source>FASEB J</source>. (<year>2017</year>) <volume>31</volume>:<fpage>3719</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700080R</pub-id><pub-id pub-id-type="pmid">28507168</pub-id></citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Ringleb</surname><given-names>M</given-names></name><name><surname>Javelle</surname><given-names>F</given-names></name><name><surname>Haunhorst</surname><given-names>S</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name><name><surname>Fennen</surname><given-names>L</given-names></name><name><surname>Baumgart</surname><given-names>S</given-names></name><etal/></person-group> <comment>Acute resistance exercise-induced changes in IL-6, IL-10, and IL-1ra in healthy adults: A systematic review and meta-analysis. <italic>medRxiv</italic>. (2023):2023&#x2013;5</comment>.</citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qing</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name></person-group>. <article-title>Exploring the association between dietary inflammatory Index and chronic pain in US adults using NHANES 1999&#x2013;2004</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>:<fpage>8726</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-58030-w</pub-id><pub-id pub-id-type="pmid">38622145</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golmohammadi</surname><given-names>M</given-names></name><name><surname>Kheirouri</surname><given-names>S</given-names></name><name><surname>Ebrahimzadeh Attari</surname><given-names>V</given-names></name><name><surname>Moludi</surname><given-names>J</given-names></name><name><surname>Sulistyowati</surname><given-names>R</given-names></name><name><surname>Nachvak</surname><given-names>SM</given-names></name><etal/></person-group> <article-title>Is there any association between dietary inflammatory index and quality of life? A systematic review</article-title>. <source>Front Nutr</source>. (<year>2022</year>) <volume>9</volume>:<fpage>1067468</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2022.1067468</pub-id><pub-id pub-id-type="pmid">36618692</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cavicchia</surname><given-names>PP</given-names></name><name><surname>Steck</surname><given-names>SE</given-names></name><name><surname>Hurley</surname><given-names>TG</given-names></name><name><surname>Hussey</surname><given-names>JR</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Ockene</surname><given-names>IS</given-names></name><etal/></person-group> <article-title>A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein</article-title>. <source>J Nutr</source>. (<year>2009</year>) <volume>139</volume>:<fpage>2365</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3945/jn.109.114025</pub-id><pub-id pub-id-type="pmid">19864399</pub-id></citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Ibraheem</surname><given-names>AMT</given-names></name><name><surname>Hameed</surname><given-names>AAZ</given-names></name><name><surname>Marsool</surname><given-names>MDM</given-names></name><name><surname>Jain</surname><given-names>H</given-names></name><name><surname>Prajjwal</surname><given-names>P</given-names></name><name><surname>Khazmi</surname><given-names>I</given-names></name><etal/></person-group> <article-title>Exercise-induced cytokines, diet, and inflammation and their role in adipose tissue metabolism</article-title>. <source>Health Sci Rep</source>. (<year>2024</year>) <volume>7</volume>:<fpage>e70034</fpage>. <pub-id pub-id-type="doi">10.1002/hsr2.70034</pub-id><pub-id pub-id-type="pmid">39221051</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>Christman</surname><given-names>JW</given-names></name></person-group>. <article-title>The role of nuclear factor-&#x03BA; B in cytokine gene regulation</article-title>. <source>Am J Respir Cell Mol Biol</source>. (<year>1997</year>) <volume>17</volume>:<fpage>3</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.17.1.f132</pub-id><pub-id pub-id-type="pmid">9224203</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeb</surname><given-names>F</given-names></name><name><surname>Osaili</surname><given-names>T</given-names></name><name><surname>Naqeeb</surname><given-names>H</given-names></name><name><surname>Faris</surname><given-names>ME</given-names></name><name><surname>Ismail</surname><given-names>LC</given-names></name><name><surname>Obaid</surname><given-names>RS</given-names></name><etal/></person-group> <article-title>Scientific basis of dietary inflammatory index (DII): a dietary tool to metabolic syndrome risk</article-title>. <source>Clin Nutr Open Sci</source>. (<year>2025</year>) <volume>61</volume>:<fpage>138</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.nutos.2025.04.002</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akbari-Fakhrabadi</surname><given-names>M</given-names></name><name><surname>Kaviani</surname><given-names>M</given-names></name><name><surname>Fern&#x00E1;ndez-L&#x00E1;zaro</surname><given-names>D</given-names></name></person-group>. <article-title>Diet and exercise- induced inflammation</article-title>. <source>Front Nutr</source>. (<year>2024</year>) <volume>11</volume>:<fpage>1438832</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2024.1438832</pub-id><pub-id pub-id-type="pmid">38953046</pub-id></citation></ref></ref-list>
</back>
</article>